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CHAPTER 1 
Overview and Rational 
 
1.1 Overview of Dissertation  
Major bone losses due to cancer trauma and other diseases have been treated with 
autografts, allografts and other bone graft substitutes.  However, these techniques have 
their limitations, such as the availability of grafts, immune responses, and stress shielding.  
As an alternative approach, porous bone scaffolds using FDA approved synthetic 
biodegradable polymers, such as poly (L-lactic acid) (PLLA), Poly (lactic-co-glycolic 
acid) (PLGA), Poly (glycolic acid) (PGA) and Poly (ε-caprolactone) (PCL), have been 
developed and examined both in vitro and in vivo.  The ideal scaffolds are required to 
support physiological loads at the defect sites, to be favorable for bone formation and 
degrade in concert with the rate of bone formation.   
The current efforts combining computer aided design and solid freeform fabrication 
(SFF) techniques enable the fabrication of porous scaffolds with controlled architectures 
for bone tissue applications using both biodegradable and non-degradable materials.  
Furthermore, biomineral coatings have been studied to improve bone tissue generation on 
and into non-osteoconductive implants, such as polyester biodegradable scaffolds. 
The goal of this study was to design and fabricate osteoconductive porous 
biodegradable scaffolds with controlled 3D architectures, to enhance bone 
generation as well as control scaffold degradation, for human trabecular bone 
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applications.  First, scaffolds with controlled architectures and mechanical properties 
within the range of human trabecular bone were designed with an image based design 
(IBD) technique and fabricated with SFF techniques.  Second, the effects of the scaffold 
architectures and materials on in vivo bone formation were determined.  Third, scaffolds 
in vivo degradation ratio depending on the pore sized were determined.  Last, the effects 
of the biomineral coating he polymer scaffolds was evaluated to improve in vivo bone 
formation. 
In the dissertation, goal of the study and rational are presented in chapter one.  Chapter 
two describes important backgrounds, including bone grafts and current scaffold 
fabrication techniques.  There are four individual studies (aims) in the thesis, and they are 
described in chapter three through six.  Lastly, the thesis was summarized, and the 
potential future directions were discussed in chapter seven. 
 
1.2 Experimental and Computational Characterization of Designed and Fabricated 
50:50PLGA Porous Scaffolds for Human Trabecular Bone (Chapter Three) 
Rationale: Ideal scaffolds for bone application are should provide mechanical 
properties which are similar to native bone tissue and have controlled structures for tissue 
formation.  Porous biodegradable scaffolds have been developed using several techniques, 
such as particle leaching, gas forming and phase separation.  However, due to their high 
porosity and thin walls between pores, they do not have sufficient mechanical strength to 
support bone defect loading.  Furthermore, the pores are randomly located, and their 
interconnectivity is not well controlled.  The goal of this study was to fabricate scaffolds 
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with designed architectures and control their mechanical properties within the range of 
the trabecular bone.   
Summary: 50:50PLGA porous scaffolds with two porosities (50% and 70%) were 
designed and fabricated using the IBD and indirect SFF techniques, and characterized 
using micro-computed tomography (µ-CT) and mechanical testing.  Scaffolds’ 
compressive moduli and yield stress were controlled by scaffold designs and within the 
range of human trabecular bone and.  µ-CT data was successfully implemented in a 
voxel-based finite element (FE) method to predict compressive moduli and yield stress 
and match to those of the experiment.  This technique can be applied for scaffold quality 
control. 
 
1.3 Effects of designed PLLA and 50:50PLGA scaffold architectures on bone 
formation in vivo (Chapter Four) 
Rationale: Engineered scaffolds should have an architecture that is favorable for bone 
formation and mechanical properties.  Conventional scaffolds have been used to 
determine the effect of scaffolds architectures on bone formation.  However, in this case, 
scaffold architecture is controlled only in terms of average pore sizes and global 
porosities, with wide variations in each.  These scaffolds furthermore have uncontrollable 
internal architectures, and limited pore interconnectivity.  The scaffolds with random 
structures may prevent body fluid infiltration, cell migration and tissue ingrowth into a 
scaffold.  As shown in chapter three, the fabricated 50:50PLGA scaffolds using the 
indirect SFF technique had orthogonally interconnected pores and mechanical properties 
within the human trabecular bone range.  SFF scaffolds were used to investigate the 
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effect of scaffold architectures and material choice on bone formation using designed and 
controlled architectures.  
Summary: Three types of porous scaffold architecture from two biodegradable 
materials, PLLA and 50:50PLGA, were designed and fabricated using image based 
design and indirect solid freeform fabrication techniques.  The fabricated scaffolds were 
seeded them with bone morphogenic protein-7 (BMP-7) transduced human gingival 
fibroblasts and implanted them subcutaneously into mice for 4 and 8 weeks.  The PLLA 
scaffolds maintained their architecture at both time points and showed improved bone 
ingrowth which followed the internal architecture of the scaffolds.  The 50:50PLGA 
scaffolds, however, degraded and did not maintain their architecture after 4 weeks.  
PLLA scaffolds maintained greater mechanical properties than 50:50PLGA after 
implantation.  The results indicated the importance of choice of scaffold materials and 
computationally designed scaffolds to control tissue formation and mechanical properties 
for desired bone tissue regeneration.  
 
1.4 Architecture Effects on Long Term In Vivo Degradation in 3D Designed PLLA 
Porous Scaffolds (Chapter Five) 
Rationale: Scaffold architectures may significantly influence in vivo degradation due 
to the geometric influences on polymer hydrolysis and the significant variations (cell 
populations, local fluid conditions) of the in vivo environment.  However, the previous 
studies used scaffolds with random pore architectures fabricated by conventional 
techniques such as salt leaching and phase separation.  In addition, many of degradation 
studies were performed in vitro which shows different profiles than in vivo degradation.  
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Therefore, it is important to determine the in vivo degradation dependence on designed 
scaffold architectures.  As examined in chapter four, PLLA scaffolds may be suitable for 
bone application compared with 50:50PLGA scaffolds due to their slower degradation.  
Therefore, the influence of initial PLLA scaffold architecture on degradation was 
examined. 
Summary: The effect of controlled scaffold initial architectures on in vivo 
degradation were examined regarding pore size, strut size, porosity and surface area. 
Three types of computer designed and solid freeform fabricated porous PLLA scaffolds 
in addition to PLLA bulk cylinders were implanted into mice subcutaneously for 6, 12 
and 21 weeks.  The cylinders lost weight faster as a percentage of initial weight than all 
porous scaffolds.  Of the scaffolds, the group with the largest strut size lost weight 
percentage the fastest, and strong correlations between the surface area and weight loss 
were found.  Scaffold porosity, however, was not significantly correlated with 
degradation rate.  Scaffold mechanical properties decreased with degradation and 
maintained modulus in the lower range of the human trabecular bone even after 21 weeks.  
This study suggests that computer design and fabrication, within a given material, control 
scaffold degradation profiles.   
 
1.5 Effect of hydroxyapatite-coated PLLA and PCL porous scaffolds on bone 
formation in vivo (Chapter Six) 
Rationale: Through chapter three to five, the effect of scaffolds architectures and 
materials were examined using PLLA and 50:50PLGA.  One of the limitations of poly 
ester biodegradable scaffolds is their poor osteoconductivity.  To enhance bone formation 
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on these non-osteoconductive substrate, biomineral coating using simulated body fluid 
has been developed.  Although varieties of biodegradable scaffolds have been 
successfully coated with biomineral coating, the effects of biomineral coated 
biodegradable scaffolds on in vivo bone formation are not well studied, especially 
scaffolds with different degradation profiles, such and PLLA and PCL.  In addition, the 
combination of SFF scaffolds with biomineral coated has also not well investigated.  
PLLA and PCL scaffolds with the same architecture were mineralized in the same 
condition to study the effect of mineralization on bone formation. 
Summary:  PLLA and PCL scaffolds with the same design were fabricated using SFF 
and coated with biomineral layers using modified simulated body fluid which were done 
by Darilis Suarez-Gonzalez in Dr. Murphy’s lab at the University of Wisconsin.  µ-CT, 
XRD and SEM data showed that both PLLA and PCL scaffolds had the identical 
structures with orthogonally interconnected pores, and their surfaces were successfully 
coated with biomineral layers.  The scaffolds were seeded with either BMP-7 or green 
fluorescent protein (GFP) tranduced human gingival fibroblasts, and then, implanted into 
mice subcutaneous sites for 3 and 10 weeks.  From µ-CT and histological data at 3 weeks, 
there is no significant difference between the coated scaffolds and uncoated scaffolds for 
both PLLA and PCL.  At 10 weeks, however, the coated scaffolds had significantly 
advanced bone ingrowth compared with the uncoated scaffolds.  The bone ingrowth 
improved the mechanical properties of PLLA scaffolds.  This study concluded that 
combination of SFF technique and biomineral coatings improve bone ingrowth of both 
PLLA and PCL scaffolds, and advanced bone ingrowth improve mechanical properties of 
PLLA scaffolds. 
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CHAPTER 2 
Background and Motivation 
 
2.1 Bone structure, composition and mechanical property 
Bone is a complex tissue and plays many significant roles to maintain the body, such 
as providing structural support, protecting organs, and storing cells and mineral ions [1,2].  
Bone tissue is composed of about 30% organic matrix, 60% inorganic mineral matrix, 
and 10% water by weight [3,4].  Type I collagen occupies 90% of the organic component, 
and the other 10% contains non collagenous proteins, such as proteoglycans and 
glycoproteins.  Structurally, bone is largely composed of two parts, compact (cortical) 
bone and cancellous (trabecular) bone (Fig 2.1) [1,4,5].  In the adult skeleton, the ratio of 
compact bone and the cancellous bone are 80 and 20%, respectively [6].  These bones 
contain the same microstructural elements, including cells, organic matrix, inorganic 
mineral matrix and soluble factors. 
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Fig 2.1 Bone Structure. Cited from [1] 
 
As reviewed in previous papers [2,6], compact bone has about 10% porosity, is 
composed of organized structures, and contains osteon which is a cylindrical shape of 
bone units 200-250 µm in diameter and oriented in longitudinal directions.  The osteon is 
also called the Harversian system and contain Haversian canals in their center which has 
blood vessels and supplies nutrients to mature bone cells (osteocytes).  The osteon 
consists of the mineralized sheets called lamellae 3-7 µm in thickness.  The collagen 
fibers are present and oriented parallel in each lamella.  Each collagen fiber is composed 
of a collagen fibril where collagen molecule and mineral crystals are arranged regularly 
[1].  Due to the highly dense structures, compact bone has high mechanical properties 
with 12-18GPa [7]. 
In contrast to compact bone, cancellous bone has active turn over and less organized 
structures [8].  It is found at the end of long bones and within some other bones including 
the spinal vertebrae, sternum and pelvis [9].  It has three dimensional highly porous 
structure with 50 -95% porosity and is filled with bone marrow and bone cells, and the 
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trabeculae have 100-300 µm thickness and 300-1,500 µm spacing [2,4,6,9].  Elastic 
moduli of cancellous bone is range from 100 to 500MPa which is much lower than that of 
compact bone [7]. 
 
2.2 Bone cells and bone formation 
Bone is an active tissue which constantly turns over to adapt to mechanical stimuli and 
repair damaged area.  Bone formation and resorption are regulated by the major bone 
cells, osteoblast, osteocyte and osteoclast [10].  Osteoblasts are derived from 
mesenchymal cells, have a rounded, oval or polyhedral shape and reside on the surface of 
bone to form new bone tissue, lamellar bone and woven bone[6].  They synthesize and 
secrete mostly type I collagen and other organic components including osteopontin, 
osteocalcin, cytokines and growth factors, and also produce and regulate calcium 
phosphate minerals [3].  After these activities, osteoblasts undergo transformation into 
osteocytes, remaining less active as bone-lining cell, and undergoing apoptosis [5,6]. 
Osteocytes are matured cells of osteoblasts, which make up more than 90% of bone 
cells in adult human bone and are embedded in the mineralized matrix [6].  A single 
osteocyte resides in small lacunae and is connected with neighboring cells through 
canaliculi to communicate each other.  In the lacunae and canaliculi system, osteocytes 
sense and respond to fluid flow change or mechanical stimuli and produce signaling 
molecules which regulate osteoblasts and osteoclasts to adjust bone formation and 
resorption [5,10-12]. 
In contrast to the other bone cells, osteoclasts are derived from hematopoietic stem 
cells and large multinucleated cells with from 3 to 30 nuclei.  Their main function is to 
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resorb mineralized bone by acidification and enzymatically degrade demineralized bone 
[5]. 
Bone formation and development occur by two distinct pathways, intramembraneous 
and endochondral bone ossification.  The intramembraneous bone formation occurs at flat 
bones in the cranium and facial bones, and some parts in the mandible [13,14].  It starts 
from the invasion of capillaries into mesenchymal zone which leads mesenchymal cells 
to turn into osteoblasts.  The osteoblasts deposits bone spicules and form trabeculae 
which become interconnected forming woven bone.  The woven bone is eventually 
replaced with lamellar bone.  During the process, some osteoblasts are caught within the 
bone matrix and become osteocytes. 
Endochondral bone formation occurs at the long, short bones and during bone 
regeneration due to bone fracture, and the process has been reported in several reviews 
[14-16].  Briefly, mesenchymal cells become condense and differentiate into 
chondrocytes as the process called precartilage condensation, and chondrocyte become 
hypertrophic at the center of the condensation.  Perichondral cells around the 
hypertrophic chondrocyte differentiate into osteoblasts which form a bone collar.  The 
hypertrophic chondrocytes continue to proliferate, are involved by blood vessels and 
eventually replaced by bone and marrow. 
 
2.3 Autografts, allografts, xenografts, and bone graft substitutes 
Over 500,000 bone graft procedures are performed annually in the US and the market 
size was about $1.5 billion in 2009, estimated to reach $3 billion by 2015 [17-19].  The 
definition of a bone graft is, “Any implanted material that, alone or in combination with 
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other materials, promotes a bone healing response by providing osteogenic, 
osteoconductive, or osteoinductive activity to a local site” [20].  Bone graft materials can 
be categorized as an autograft, allograft, xeonograft, and synthetic materials.   
Autografts, which are obtained and implanted into the same patient, are recognized as 
the gold standard for most procedures [20-22].  For example, cancellous bone autograft 
contains hydroxyapaptite and collagen as osteoconductive material, stromal cells as 
osteogenic cells and growth factors as for osteoinduction [23].  However, the major 
disadvantages of autografts are limited availability of tissues, second surgery, donor site 
morbidity and increased blood loss [24].   
Allografts, which are harvested from one individual and implanted into another 
individual of the same species, comprise about one third of the bone grafts used in North 
America [20,25].  They are more available than the autografts and do not require the 
second surgery to patients. However, host immune reactions or disease transmissions 
including HIV, hepatitis B and C, are major problems, and supply of cadaveric bone is 
not abundant [23,26].  To lower the risk of immune reaction, allograft processing and 
sterilization are used such as freeze-drying, demineralization, irradiation and ethylene 
oxide.  These techniques also sacrifice oseoinductivity and osteogenic capability of 
allografts, and furthermore, the mechanical properties of the graft are also altered. 
Xenografts are harvested from one species (animal) and implanted into another 
individual of different species [20,27].  The grafts have significant immune response, and 
therefore are not favorable.  Although the immune response can be reduced using 
deproteinization and deffatting, osteoinductive proteins are also terminated. 
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Due to the limitations of the aforementioned grafts, metal and ceramics have been 
used as bone grafts.  Metal implants, including stainless steel, titanium and cobalt, are 
applied to fracture healing and spine fusion [28,29].  However, they are neither 
osteoinductive nor osteoconductive.  Their mechanical properties far stronger than the 
bone tissues which causes stress shielding.  Ceramics are inorganic materials with 
crystalline structures produced by high temperatures, and include calcium phosphate, 
calcium sulfate and hydroxyapatite [20,30].  Their osteoconductivity is favorable for 
bone formation.  However, the mechanical properties due to brittleness as well as their 
resorption rate do not satisfy load bearing applications.  For example, tricalcium 
phosphate with Ca:P ratio of 1.5 absorbed too fast, while hydroxyapaptite with a Ca:P 
raito of 1.67 has too long degradation[30]. 
 
2.4 Biodegradable synthetic polymers 
Biodegradable materials have been applied to orthopaedic and spine products towing 
to the ability to degrade and thereby avoid surgery for implant removal, proper 
mechanical properties and their radiolucency.  Many biodegradable polymers belong to 
the polyester family and are available including poly orthoester, poly dioxanoe (PDS), 
poly (ε-caprolactone) (PCL), polyhydroxybutyrate (PHB), polylactide (PLA) and 
polyglycolide (PGA) [28,31,32].  Especially PLA, PGA and their co-polymer (PLGA) 
have been widely used as orthopaedics products, such as pins, fixations, and screws, and 
tissue engineering applications over the past two decades.  Their chemical properties and 
degradation in animal tissues have been widely investigated [31,33-36].  Therefore, 
PLLA and PLGA were mostly used as scaffold materials in this thesis.  PGA was also 
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used for preliminary purpose to find the bulk property and manufacturability of such 
scaffolds. 
PLA, PGA and PLGA belong to poly (α-hydroxy acid) group and degrade in the body 
by hydrolysis of ester bonds and forms lactic acid and/or glycolic acid [31,35,36].  Lactic 
acid and glycolic acid are further broken down to pyruvate by lactate dehydrogenase, and 
enter the citric acid cycle, where they are converted and removed from the body as 
carbon dioxide and water.  Glycolic acid is also removed through urine. 
PLA and PGA can be obtained from the ring opening polymerization of lactide or 
glycolide (Fig 2.2 (a, b)), and PLGA can be formed via copolymerization of lactide and 
glycolide (Fig 2.2 (c)).  PLA has two optical stereo-isomers, d(-) and l(+) and racimid 
(d,l), and l- isomer, and Poly (l-lactic acid) (PLLA) is commonly used [31,33,34].  PLLA 
is a semi-crystalline polymer with about 37% crystalline, and has a 175-178°C melting 
point and 60-65°C glass transition temperature.  It has higher crystallinity about 45-55%, 
melting point (220-225°C) and glass transition temperature (35-40°C) than PLA.  It is 
also more hydrophilic than PLA, which causes faster degradation.  Degradation of PLGA 
can be adjusted by varying the ratio of lactide and glycolide with non-linear relations.  
Generally, PLGA with the copolymer ratio of 50:50 shows the fastest degradation.  
PCL is more likely used for tissue engineering scaffolds and drug delivery due to its 
long degradation time [31,37].  It is synthesized through the ring opening polymerization 
of cyclic monomer ε-caprolactone (Fig 2.2 (d)).  This polymer has low melting point 
about 59-64 °C and a glass transition temperature of -60°C [31,33].  
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Fig 2.2 Chemical Structures of PLLA (a), PGA (b), PLGA (c) and PCL (d).  Cited and modified from [33] . 
 
Mechanical properties of PLLA, PGA, PLGA, and PCL vary depending on polymer 
types and their molecular weights.  We have preliminary fabricated cubes of PLLA, 
50:50PLGA and PGA using melt casting to test their compressive moduli and yield stress, 
and also compared these with PCL cubes fabricated using a SLS system (PCL data 
provided by Colleen Flanagan).  As shown in Fig 2.3, PGA cubes show the highest 
compressive modulus and yield strength. PLLA and 50:50 PLGA cubes have lower 
mechanical properties than those of PGA cubes, however, the bulk moduli are higher 
than those of trabecular bone.  In contrast, the reported bulk mechanical properties of 
PCL are significantly lower than the others. 
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Fig 2.3 Compressive moduli (a) and yield stress (b) of bulk polymers, PLLA, 50:50PLGA, PGA and PCL.  
PCL cubes were fabricated using a SLS system (PCL data provided by Colleen Flanagan). 
 
2.5 Computational design and solid freeform fabrication 
Tissue engineered scaffolds have been developed as an alternative methods of the 
current bone grafts using varieties of biodegradable materials.  Scaffolds should have 
interconnected porous architectures for tissue integration, and furthermore have sufficient 
mechanical properties to match and support physiological loading, then degrade in a 
favorable manner to transfer load support to tissues during healing [35,38-40].  In 
attempting to achieve these requirements, biodegradable porous bone scaffolds have 
conventionally been fabricated using several methods, including phase separation [41-43], 
particle leaching [44-46], gas foaming [47] and electrospining [48-51].  All of these 
techniques are relatively easy to access and able to use a variety of materials including 
PLLA, PLGA and PCL.  Furthermore, the fabricated scaffolds can achieve high porosity 
(~90%) and high surface area to support cell migration and proliferation.  However, they 
do not have sufficient mechanical strength to support loading in bone defect sites [7] due 
to their high porosity and thin walls between pores.  In addition, uncontrolled 
architectures including, poor pore interconnectivities, prevent cell infiltration and tissue 
ingrowth or further surface modification since these scaffolds are controlled their pore 
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diameters and overall scaffold porosities with changing variables, such as porogen 
diameter, [52-54].   
Computer aided tissue engineering is a proven method to achieve desired engineering 
scaffolds and to characterize fabricated scaffolds using computer aided design (CAD), 
computed tomography(CT) and Finite element analysis (FEA) [55,56].  In addition, the 
image based design technique has been used to design scaffolds to mimic anatomical and 
physical properties of human bone [57-59].  Then, computer designed scaffolds can be 
fabricated using solid freeform fabrication (SFF) methods or rapid prototyping (RP) 
techniques, where 3D scaffolds are built in a layer-by-layer manner [39,60-62].  Various 
SFF techniques have been developed, such as stereolithography (SLA) [54,63,64], 
selective laser sintering (SLS) [55,65-67], fused deposition molding (FDM) [68,69], 3D 
printing [70-72] and 3D-plotting [73,74].   
Each technique is run with unique system and fabricates scaffolds with different 
biodegradable materials as shown in Fig 2.4.  Utilizing ultraviolet photo-curable 
monomer (Fig 2.4 (a)), SLA technique create designed scaffolds using poly (D,L-lactide) 
and poly (propylene fumarate) (PPF)-diethyl fumarate (DEF), and good cell behaviors 
were shown in the fully interconnected architectures [54,64].  In SLS system (Fig 2.4 (b)), 
powdered materials are fused by a laser beam, and various shapes of PCL scaffolds 
fabricated to apply in vivo.  For example, mandibular condyle scaffolds based on CT data 
were fabricated and implanted to pig models [75].  In FDM system (Fig 2.4 (c)), material 
is melted and extruded from a nozzle.  FDM techniques are extensively developed to 
fabricate PCL scaffolds and PCL-HA composite scaffolds for human clinical trials, and 
the scaffolds were approved by FDA [61].  3D printing technique utilizes a liquid binder 
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ejected from a printer head to bind powdered material (Fig 2.4 (d)).  This technique has 
been used to create calcium phosphate scaffolds and calcium phosphate-PLGA composite 
scaffolds, and the scaffolds for bone or osteochondral applications [70-72].  Compared 
with the previous techniques, 3D bioplotter have unique feature to fabricate hydrogel 
scaffolds by dispensing a material into liquid medium (Fig 2.4 (e)).  This system is 
operated in a sterile laminar flow and able to incorporate live cells for soft tissue 
applications [73]. 
 
Fig 2.4 Schematics of various SFF systems.  Stereolithography (SLA) (a), Selective laser sintering (SLS) 
(b), Fused deposition modeling (c), 3D printing (d), Bioplotter (f), and Wax printing (f) cited from [55].  
 
Although the aforementioned SFF techniques have been widely accepted for tissue 
engineering scaffold fabrication, the techniques has not been fully applicable to fabricate 
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PLLA, PLGA, and PGA scaffolds with complex architectures due to their high melting 
temperatures and viscosities.   We chose the indirect SFF method, which developed by 
Taboas et al [76] using wax printing system (Fig 2.4 (f)), to fabricate our scaffolds.  
Briefly, designed scaffolds image representations were converted to stereolithography 
(STL) formats and sliced in Modelworks software (Solidscape, Inc., Merrimack, NH) to 
fabricate wax molds using a ModelMaker II or PatternMaster  3D printer (Solidscape, 
Inc., Merrimack, NH).  The wax molds were cast into hydroxyapatite ceramic (HA) 
secondary molds.  Polymer pellets were heated at required temperature of each polymer 
and melted in a Teflon mold.  The HA molds were then placed into the Teflon mold 
containing molten polymer, in order to force the polymer through the open pore network.  
The HA molds were then removed from the porous polymer scaffolds using RDO Rapid 
Decalcifier (APEX Engineering Products Corp, Plainfield, IL).  The fabricated scaffolds 
were rinsed with 100% ethanol for further experiments.  We preliminary fabricated 
designed PLLA and PGA scaffolds which have high melting temperature as mentioned 
earlier (Fig 2.5). 
 
Fig 2.5 PLLA scaffold (a) and PGA scaffold fabricated by indirect SFF technique 
 
2.6 Biomineral coating 
One of the disadvantages of many polymeric and metallic biomaterials is their non-
osteoconductive property compared with hydroxyapatite (HA) and tricalcium phosphate 
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(TCP) scaffolds.  To improve ostoconductivity of biomaterials, a biomineral coating of 
substrate surfaces using simulated body fluid (SBF) is a unique technique and was 
developed by Kokubo et al [77].  Many researchers have shown mineralization with 
various substrates to compensate for their non-osteoconductivities.  In this technique, the 
negatively charged surfaces of substrates are created using various techniques, such as 
hydrolysis.  The substrates are immersed SBF which has similar ion contents as human 
blood plasma. Carbonate apatite minerals which are similar to the mineral component of 
bone tissue are deposit with less than 30µm thickness on the substrates [78,79].  This 
technique has successfully been applied to various biomaterials including metals [80-82], 
polymers [78,83-86], and the composites of polymers and hydroxyapatite [84,87] to 
enhance bone cell function and bone tissue regeneration.   
However, the effects of mineral coatings on bone formation in 3D designed porous 
polymer scaffolds have not been thoroughly studied.  Some studies showed that there was 
no significant effect on mineral coating of biodegradable polymers on bone formation 
[84,85].  Another study demonstrated that mineral coated salt leaching scaffolds tend to 
have less open pore structures which terminate effectively coat at the center of the 
scaffolds and have undeveloped bone ingrowth towards the center of the scaffolds [53].  
Therefore, we developed biomineral coated biodegradable SFF scaffolds with 
interconnected pores to enhance in vivo bone formation.  As mentioned in chapter one, 
SFF scaffolds were fabricated by our group and then, coated with biomineral layers by 
Prof. Willam Murphy’s group in the University of Wisconsin. 
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2.7 Ectopic bone formation using ex vivo gene therapy 
We used mice ectopic sites to test our scaffolds for chapter four, five and six.  Ex vivo 
gene therapy was used to induce bone formation on and into the scaffolds (chapter four 
and six) [88,89].  This regenerative gene therapy strategy using adenoviral vectors can be 
applied to transduce various cells, such as bone marrow stromal cells [90], and fibroblasts 
[91,92].  The tranceduced cells secrete proteins, such as BMP-7 and BMP-2, to recruit 
and induce host cells towards osteogenesis.  Additionally, this approach has been studied 
to induce endochondral-like bone tissue formation by transduced HGFs [91,93].  We 
have been seeding BMP-7 transduced human gingival fibroblasts and seeding them to 
porous SFF scaffolds to facilitate bone generation in mice ectopic sites [66,94-96].   All 
of our previous studies showed that good bone formation in and on to the scaffolds.  
Therefore, ex vivo gene therapy is a good technique to form bone tissues to test our 
scaffolds.  
Ectopic site has been used to test biodegradable bone scaffolds including PLLA and 
PLGA.  The major advantages of this model are relatively easy to implant and harvest 
scaffolds, and achieve large numbers of replicates for preliminary study.  Some surgical 
complication may need to be considered to implant scaffolds into orthotopic sites due to 
removing or cutting existing bone tissues surrounded by blood vessels and nerve tissues.  
However, the limitation of the ectopic model is not identical to the orthotopic sites and 
there are some study compared ectopic models with orthotopic models for the sake of 
bone tissue engineering research.  For example, in ectopic model, there are delays of 
vascularization causing delay of bone ingrowth into porous constructs as well as lack of 
fracture healing response [97,98].   Furthermore, there is lack of mechanical signal in 
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ectopic sites which would affect bone formation and scaffolds degradation. [99-101].  In 
spite of some limitations, ectopic model is still useful to evaluate our scaffolds to perform 
preliminary studies.  This model allows easily implanting and harvesting scaffolds 
without further complications.  
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CHAPTER 3 
Experimental and Computational Characterization of Designed and Fabricated 
50:50 PLGA Porous Scaffolds for Human Trabecular Bone Applications 
 
3.1 Abstract 
 The present study utilizes image-based computational methods and indirect solid 
freeform fabrication (SFF) technique to design and fabricate porous scaffolds, and then 
computationally estimates their elastic modulus and yield stress with experimental 
validation.  50:50 Poly (lactide-co-glycolide acid) (50:50 PLGA) porous scaffolds were 
designed using an image-based design technique, fabricated using indirect SFF technique, 
and characterized using micro-computed tomography (µ-CT) and mechanical testing.  µ-
CT data was further used to non-destructively predict the scaffold elastic moduli and 
yield stress using a voxel-based finite element (FE) method, a technique that could find 
application in eventual scaffold quality control.  µ-CT data analysis confirmed that the 
fabricated scaffolds had controlled pore sizes, orthogonally interconnected pores and 
porosities which were identical to those of the designed files.  Mechanical tests revealed 
that the compressive modulus and yield stresses were in the range of human trabecular 
bone.  The results of FE analysis showed that potential stress concentrations inside of the 
fabricated scaffold due to fabrication defects.  Furthermore, the predicted moduli and 
yield stresses of the FE analysis showed strong correlations with those of the experiments.  
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In the present study, we successfully fabricated scaffolds with designed architectures as 
well as predicted their mechanical properties in a nondestructive manner. 
 
3.2 Introduction 
Tissue engineering scaffolds have been studied as temporary templates for defects in 
the body to support loads, cell attachment and tissue regeneration.  To enhance bone 
tissue integration into the constructs, scaffolds should have interconnected porous 
architectures for cell migration and blood vessel infiltration [1].  It is also necessary to 
have sufficient mechanical properties to match and support physiological loading, which 
degrade in a favorable manner to transfer load support to tissues during healing [2-4].  To 
fulfill these requirements, it is necessary to design and fabricate scaffolds with controlled 
porous architectures [5,6]. 
Biodegradable porous bone scaffolds have been fabricated using several methods, 
including phase separation [7-10], particle leaching [5,11,12] and gas foaming [13].  
These techniques can achieve high porosities (~90%) and large surface area for cell 
adhesion and tissue regeneration.  These techniques further incorporate hydroxyapatite or 
bioactive glass to increase the scaffolds mechanical properties [14,15].  However, due to 
their high porosity and thin walls between pores, they do not have sufficient mechanical 
strength to support bone defect loading [16].  Furthermore, the pores are randomly 
located, and their interconnectivities are not well controlled.  Although the mean pore 
diameter and overall scaffold porosity can be controlled by changing fabrication 
parameters like porogen diameters, it is impossible to precisely control pore location, 
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pore diameter, pore interconnectivity, wall thickness, and wall location [17].  Therefore, 
the internal pore architectures of those scaffolds cannot be designed.  
To fabricate designed scaffolds with higher mechanical properties and interconnected 
pores, researchers have studied solid freeform fabrication (SFF) methods with various 
rapid prototyping (RP) machines, such as stereolithography (SLA) [18], selective laser 
sintering (SLS) [19,20], fused deposition molding (FDM) [21,22] and  3D printing [23].  
These techniques enable fabrication of scaffolds with a high mechanical modulus and 
well interconnected pore structures compared to the aforementioned techniques of 
porogen leaching, gas foaming and phase separation.  Although SFF techniques expand 
the capability of fabrication of designed scaffolds, only a limited numbers of materials 
can be used due to their temperature limitation, or chemical cross linking methods [24].  
To address these limitations, indirect SFF technique is another unique and versatile 
technique using inverse molding to cast custom scaffolds [25].  In this technique, the 
inverse molds of the desired scaffold shapes are fabricated using rapid prototyping 
machines, such as SLA or other 3D printing machines.  These secondary molds are then 
cast into the desired polymer or polymer solution.  This technique has increased the 
material choices of scaffolds with various synthetic biodegradable polymers, including 
poly lactic acid (PLA) [26], poly glycolic acid (PGA) [25], poly propylene fumerate 
(PPF) [27,28], poly ε-carprolactone (PCL) [29] and a composite of poly (propylene 
fumerate) /tricalcium phosphate (PPF/TCP) [30,31].     
Poly (lactide-co-glycolide acid) (PLGA) is a FDA approved biodegradable material 
[32] and has been widely studied both in vitro and in vivo.  Many previous studies have 
shown low mechanical properties for load bearing purposes [5,6,13,33-36].  Although 
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some researchers achieved high compressive moduli, about 40MPa to 400MPa, their 
scaffolds are still not well controlled for pore size and porosity [11,37,38].  We postulate 
that PLGA porous scaffolds can be fabricated using indirect SFF technique with 
controlled internal architectures and compressive modulus for load bearing sites.  
A critical need for scaffold engineering is the ability to a priori design scaffolds for 
desired effective properties, to non-destructively assess how closely the fabricated 
scaffold compares to its design and to investigate if differences between designed and 
fabricated properties can be determined from fabrication artifacts using computer aided 
design (CAD), computed tomography (CT) and finite element analysis (FEA) [19,39].  
Image-based design (IBD) techniques have been utilized to design scaffolds that mimic 
anatomical and physical properties of human bone [40-42], and readily interface with 
indirect SFF technique to fabricate designed scaffolds.  In addition, micro-computed 
tomography (µ-CT) has been utilized to assess the fabricated scaffolds architecture in a 
nondestructive manner [43,44].  Subsequently, the µ-CT techniques have been combined 
with voxel-based FEA to estimate scaffold mechanical properties and compare with 
experimental mechanical properties [20,45-48].    
In this study, the porous scaffolds were designed by IBD and fabricated by indirect 
SFF technique to evaluate the ability to control scaffold architecture and mechanical 
properties.  We hypothesized that designed 50:50 PLGA porous scaffolds could be 
fabricated using indirect SFF technique whose compressive moduli and yield stresses 
were within the range of the human trabecular bone.  In addition, those mechanical 
properties could be computationally predicted from non-destructive µ-CT scans using 
voxel-based finite element method.  To assess this hypothesis, we designed three 
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porosities, 0, 50, and 70%, of porous scaffolds with orthogonally interconnected pores 
using IBD and fabricated these scaffolds from 50:50 PLGA scaffolds using indirect SFF 
technique.  We then measured the porosities, pore size and strut diameter of the 
fabricated scaffolds using μ-CT. Compressive moduli and strength of three orthogonal 
directions were measured by mechanical testing.  Voxel-based FE methods were used to 
simulate both the designed and the fabricated scaffolds in order to computationally obtain 
elastic moduli and yield stresses.  These values were compared to the experimental elastic 
moduli and yield stresses. 
 
3.3 Methods 
3.3.1 Material 
50:50 PLGA (lot D#01080, Inherent Viscosity = 0.61dL/g) was purchased from 
Birmingham Polymers, Inc. (Birmingham, AL) and preserved in a container with 
desiccants at -20˚C to prevent moisture buildup.  The polymer was left at room 
temperature for 30 minutes before further processing.   
 
3.3.2 50:50 PLGA Solid Cube Fabrications 
50:50 PLGA solid cubes with 0% porosity were fabricated in a customized 
polytetrafluoroethylene (PTFE) mold with 7x7mm square holes.  The Teflon mold was 
preheated in the oven for 30 minutes, and the polymer pellets were periodically added to 
the mold until the desired volume was achieved and heated in a vacuum oven at 170 C 
for 3.5hours.  The cubes were cooled to 100 C for 0.5 hours, and then to room 
temperature.  After removing the Teflon mold, 50:50 PLGA cubes were trimmed to 
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become 7mm height.  X, Y, Z orientations of the solid cubes were determined as shown 
in Fig 3.1 (e). 
 
3.3.3 50:50 PLGA Porous Scaffold Fabrication 
Porous scaffolds with interconnected pores were fabricated using the indirect SFF 
technique as previously described [25].  An image of each step is shown in Fig 3.1 (a - d).  
First, two porous scaffold designs with 50 % and 70% porosities were designed by IBD 
method using the interactive data language (IDL) software (Research Systems, Inc., 
Boulder, CO) [40].  The orthogonally interconnecting pores were generated as a unit cell 
and replicated to fill the cubic volume.  The external shapes of scaffolds were designed 
into 7mm cubic shapes which were filled with the designed unit cells containing pore and 
struts. The pore and strut sizes of each scaffold were 664μm and 464μm respectively for 
the 50% porous scaffold, and 878μm and 228μm respectively for the 70% porous 
scaffold.  The IDL generated image-based designs of the scaffolds were converted into 
stereolithography (STL) format,  then, sliced using Modelworks software (Solidscape, 
Inc., Merrimack, NH), and finally read by PatternMaster  3D printer (Solidscape, Inc., 
Merrimack, NH) to fabricate wax molds.  
Our fabrication method for the HA molds have been reported previously [49,50].  
From our previous research, HA has been known to shrink during the sintering process, 
and we designed the HA secondary molds to account for this, by a scaling factor of 1.37 
[25].  HA slurry was casted into the wax molds, cured in a nitrogen atmosphere overnight 
under a fume hood for one day, and immersed in acetone to remove the wax molds.  The 
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HA molds were cyclically burned out in the furnace to remove the polymer binding the 
HA particles and then, sintered at 1350˚C.  
The 50:50PLGA polymer pellets were added to the PTFE molds with a square hole to 
fit the HA secondary mold.  The HA molds were then placed into the PTFE mold 
containing the molten PLGA polymer, and pushed through until the HA molds reached 
the bottom of the PTFE mold in order to force the polymer to penetrate into the open pore 
networks of the HA molds.  The remainder of the casting protocol is identical to the solid 
cube fabrication. The polymer scaffolds containing HA molds were ground with a hand-
milling machine to expose the HA on the surface of the scaffolds and submersed in RDO 
(APEX Engineering Products Corp, Plainfield, IL) under fluid agitation to remove HA 
from the porous polymer scaffold.  Every 1 to 1.5 hours, the scaffold was blown with air 
to clean out residual HA.  X, Y and Z directions of scaffolds were determined and 
marked (Fig 3.1).  After the HA was removed from the scaffolds, polymer scaffolds were 
washed with ethanol, dried and returned to the freezer. 
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Fig 3.1 Images of the scaffold fabrication process.  (a) A porous scaffold was designed using IBD 
techniques and converted into stil file format.  (b) A thermoplastic mold was fabricated using PatternMaster 
rapid prototyping machine.  (c) A hydroxyapatite secondary mold was cast into the thermoplastic mold 
followed by burning and sintering process.  (d) 50:50 PLGA porous scaffold was cast into the HA 
secondary mold and the HA mold was removed by RDO. (e) Orientation of the fabricated scaffolds.  The 
orientations of the scaffolds were defined along to the casting directions.  Green color represents one of the 
Teflon molds, and there are two Teflon plates attached both size in X direction. 
 
3.3.4 Characterization of Fabricated Scaffold Morphology and Volume Fraction   
Determination of the fabricated scaffold morphology, pore sizes, pore 
interconnectivity and volume fraction was done using a MS-130 high resolution Micro-
CT Scanner (GE Medical Systems, Toronto, CAN).  All of the solid cubic, 50% and 70% 
porous scaffolds were scanned at a resolution of 16 m.  The source volume was 75kV 
and 75 mA and an aluminum filter was used.  The scanned images were reconstructed 
using Microview software (GE Healthcare) and stored as .vff files. To determine the 
volume fraction of the scaffolds, the vff files were reoriented and output as .jpg files 
using Microview software.  Finally, regions of interest (ROI) from the .jpg images were 
determined and converted to raw files, and the raw files were used to automatically 
calculate the fraction of volume using IDL software.  The ROI was chosen to contain the 
entire scaffold, but not any area outside of the scaffold. 
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3.3.5 Mechanical Testing 
Compression tests were performed at a rate of 1mm/min after a preload of 0.454kg 
(1lb) using a MTS Alliance RT30 Electromechanical test frame (MTS Systems Corp., 
MN).  After scanning, all scaffolds were compressed to failure in one of three orthogonal 
directions (X, Y, Z) defined in the scaffold fabrication section.  TestWorks4 software 
(MTS Systems Corp., MN) was used to record load and displacement data, and stress-
strain curves were calculated from the initial dimensions of the specimens.  The 
compressive modulus was defined by the slope at the initial linear section of the stress-
strain curve.  The yield stresses were calculated using the 0.2% offset method.  One-Way 
ANOVA was performed using SPSS (SPSS, Inc., Chicago, IL USA), with significance 
defined as p < 0.05. 
 
3.3.6 Finite Element (FE) Analysis of Fabricated Scaffold  
The µ-CT scanned scaffolds were simulated using a voxel-based FE method to 
compare the compressive moduli with those of the experiments.  The 3D .vff files were 
converted to Analyze.hdr format using the Microview software, and then imported into 
the ScanIP
TM
 software (Simpleware Ltd. UK.).  The imported files were processed and 
exported into .stl formats.  The stl files were imported into the voxel-based 
homogenization software, VOXELCON (Quint Corp, Tokyo, Japan), to create voxel, or 
equivalently 8-node hexahedral elements.  The input moduli (Ex = 2706.5MPa, Ey = 
2845.5MPa, Ez = 2986.9MPa) were determined from the compressive tests of the solid 
cubes and Poisson’s ratio of 0.3 was assumed for all models.  The voxel size with 30μm 
was applied to 50% and 70% porous scaffolds, and the voxel size with 50 μm was 
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applied to the solid cubes.  The uniaxial loads in z direction are applied to one side of the 
models, and the other sides were confined in z direction.  One voxel (not one node) of the 
constrained side was constrained with X and Y direction to prevent the rotation of the 
model.  Convergence was achieved when the force and displacement residuals were less 
than 1 × 10
-4
.    
 
3.3.6.1 Prediction of modulus and yield stress of the designed porous scaffolds 
Two loads were applied to the structure within the linear region of scaffold 
deformation.  One was applied at the lower end of the linear region and one was applied 
at the upper end of the linear region.  Since elastic modulus is linear, it could be 
determined from either applied load.   The effective scaffold modulus was calculated as 
the slope of the applied stress (applied load/cross-sectional area) versus average strain 
(maximum displacement/initial length).  To determine the yield stress of the designed 
scaffolds, the maximum stress of the voxels under each applied stress of the designed 
scaffold was calculated.  Then, the relation between the applied stress and the maximum 
stress were plotted.  Finally, the yield stress was determined at the point where the 
maximum stress reached value of the bulk yield stress. 
 
3.3.6.2 Prediction of modulus and yield stress of the fabricated porous scaffolds 
The effective moduli of the fabricated porous scaffold (n = 9) were calculated in the 
same way as the porous scaffold designs.  For yield stress calculation (n = 8), cumulative 
histograms of von Mises stress distributions were plotted. Then, the histograms were fit 
to a modified cumulative Weibull function (eq.1) which includes two exponential terms.  
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rxx ppxf       (Eq. 1) 
Where p is a weighting value for the exponential terms, k1 and k2 are the shape 
parameters, and λ and r are scale parameters of the fitting curve.  The modified Weibull 
function was fit using the FMINCON optimization routine in MATLAB.  After several 
tests, p values clustered around 0.1.  Therefore, p was chosen as 0.1 in this study.  k1, k2 
and r were found to be constant over the analyses for a scaffold regardless of the applied 
loads. It was also found that λ was proportional to the applied loads. Here, we introduced 
ε, a fraction of voxels having von Mises stress higher than the bulk yield stress (110MPa 
from our experiments).  For given p, k1, k2 and r, λ at yield was determined for a given ε 
by eq 1. Also we calculated λ from bulk yield for given ε by direct relation in eq 1. Then, 
by interpolating two applied loads (high applied load (larger λ) and lower applied load 
(smaller λ)), we obtained the yield stress of the scaffold (Fig 3.7 (b)).  Prediction was 
performed with various ε values (0.0001, 0.0003, 0.0005, 0.001, 0.002, and 0.003) and 
correlated to the experimental yield stresses.   
 
3.4 Result   
3.4.1 Assay of Scaffold Morphology 
We designed and fabricated 18 of the 70% porous scaffolds, 16 of the 50% porous 
scaffolds and 25 solid cubes.  As shown in Fig 3.2 (a) and (d), the designs of porous 
scaffolds were composed of repeating unit cells with orthogonally interconnected pores 
in three directions and fitted to the desired outer dimensions of the porous scaffolds using 
the IBD technique.  The three dimensional renderings of the fabricated scaffolds were 
obtained from the µ-CT data. The images revealed that the fabricated scaffolds (Fig 3.2 
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(b) and (e)) matched well with the designed architectures (Fig 3.2 (a) and (d)) and were 
composed of the repeated unit cells.  Some cracks and undesired pores in the struts from 
the fabrication process were observed (Fig 3.2 (c) and (e)).  Also, some residual 
hydroxyapatite was found inside of the scaffolds (data is not shown).   
 
Fig 3.2 Images of 50% porous 50:50PLGA scaffold (a, b, c) and 70% porous scaffold (d, e, f). stl image of 
the designed scaffold (a, d).   3D rendering images of the fabricated scaffolds (b, e).  µ-CT images of 
fabricated scaffolds shows pore interconnectivity of fabricated scaffold and some defects inside of the 
scaffolds (c, f) 
 
The volume fraction (inverse of porosity) was determined by taking the volume of 
polymer divided by total scaffold volume.  The targeted volume fractions of 70% and 
50% porous scaffolds and solid cubes were 30%, 50% and 100% while the measured 
volume fractions were 23.6 ± 5.018 %, 41.7 ± 4.558 %, and 99.7 ± 0.789 % respectively.  
The interconnected pore diameters and strut sizes adjacent to the pores were measured 
from the µ-CT images.  The average measured pore and strut sizes [Designed pore and 
strut sizes are in brackets] were 807 ± 49μm [878μm] and 296 ± 48μm [228μm] for the 
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70% porous scaffolds, and 652 ± 44μm [664μm] and 444 ± 51μm [464μm] for the 50% 
porous scaffolds.   
 
3.4.2 Mechanical Properties of the fabricated Porous Scaffolds 
The results of mechanical testing revealed that the compressive modulus and the yield 
stress varied depending on porosity of the scaffolds.  The average modulus of the solid 
cube was obtained as 2851.9 ± 133.5 MPa.  70% porous scaffolds and 50% porous 
scaffolds had achieved an average modulus of 89.5 ± 36.8 MPa and 321.6 ± 140.9 MPa, 
respectively.  The average offset yield stress also changed depending on the porosity of 
the scaffolds.  The values were 2.1 ± 1.2 MPa, 10.3 ± 4.3 MPa and 110.4 ± 2.7 MPa for 
70% porous, 50% porous and solid cubes respectively.   
The anisotropy of the scaffold moduli and yield stresses were further examined (Fig 
3.3 and Table 3.1).  The results from the solid cube compressive modului revealed that 
anisotropy was determined by casting orientation.  The anisotropy of solid cubes showed 
the highest modulus in order of Z (2986.9 ± 35.8 MPa), Y (2845.5 ± 34.7 MPa) then, X 
(2706.5 ± 103.9 MPa) direction, and these were significantly different (p < 0.05).  The 
results of the yield stresses showed only Y direction was significantly lower that Z 
direction.  Although both compressive modulus and yield stress were slightly higher in Z 
direction of 70% porous scaffold and Y direction of 50% porous scaffold, the statistical 
results did not show any significant difference. 
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Fig 3.3 Scaffold anisotropy in terms of compressive modulus (a) and yield stress (b). The value of 
compressive modulus and yield stress are shown in table 3.1. 
 
Table 3.1 Compressive modulus and Yield stress of the scaffolds with 3 orthogonal directions. 
 X Y Z 
70% Porous 
Scaffold 
N 
E (MPa) 
σ (MPa) 
6 
77.6 ± 40.7 
2.1 ± 1.3 
6 
69.5 ± 41.5 
1.7 ± 1.0 
6 
121.6 ± 58.4 
2.5 ± 1.2 
50% Porous 
Scaffold 
N 
E (MPa) 
σ (MPa) 
6 
267.7 ± 39.5 
8.4 ± 1.5 
6 
407.7 ± 156.9 
12.1 ± 4.6 
4 
273.2 ± 178.4 
10.5 ± 7.3 (N = 3) 
Solid cube 
N 
E (MPa) 
σ (MPa) 
8 
2706.5 ± 103.9 
110.7 ± 2.6 
8 
2845.5 ± 34.7 
108.4 ± 2.4 
9 
2986.9 ± 35.8 
111.8 ± 2.0 
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The mechanical test data of the 70% and 50% porous scaffolds were used to calculate 
the correlation between scaffold volume fraction and compressive modulus or yield stress 
depending on the scaffold test directions (Fig 3.4).  The compressive modulus result 
shows their linear relations and the regression values were 0.9061, 0.9002 and 0.8248 in 
all directions. These results show the porous scaffold modulus range could be varied from 
50 to 500 MPa depending on the scaffold porosities.  In addition, the yield stress showed 
a significant correlation in σx (R2 = 0.8397) and σy (R2 = 0.8929), but there is a weak 
relation in σz (R2 = 0.3327). 
 
Fig 3.4 Correlation of scaffold volume fraction with compressive modulus (a) and yield stress (b).  
The linear fitting curves are;            (Ex and σx),            (Ey and σy),             (Ez and σz). 
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3.4.3 Computational Simulation of solid cubes and Porous Scaffolds 
  
3.4.3.1 Stress distribution of the designed and fabricated scaffolds  
Fig 3.5 shows that stress distributions in Z direction from the FE simulation within 
the range of linear elastic region of the scaffolds (1~2% strain).  The different color 
shows the different stress levels where red indicates the highest tensile stress (50MPa), 
blue indicates the highest compressive stress (-110MPa) and yellow indicates zero stress 
(0MPa).  The designed porous scaffolds showed homogeneous stress in the Z direction 
(Fig 3.5 (b, c)), and higher stress concentrations appeared on the small struts on both 
designed porous scaffolds.  The fabricated scaffolds demonstrated sporadic local 
compressive stress and tensile stress concentrations due to some casting defects in the 
scaffolds (Fig 3.5 (e, f)).  Although there were minor stress concentrations on the 
fabricated scaffolds, the stress was distributed homogenously on the entire model as the 
designed cube.  The distributions of the stresses of the fabricated porous scaffolds were 
similar in both designed and the fabricated scaffolds.   
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Fig 3.5 The Z-stress distributions of simulated scaffolds in the linear elastic regions (1~2% strain): (a) 
designed cube, (b) designed 50% porous scaffold, (c) designed 70% porous scaffold, (d) fabricated cube, 
(e) fabricated 50% porous scaffold, and (f) fabricated 70% porous scaffold.  (g) Scale bar of the stress 
ranges are -110 MPa (blue) to 50 MPa (red), and the yellow shows around 0MPa stress. 
 
Potential high stress concentrations in the fabricated scaffolds were also discovered 
using the FE simulation.  Fig 3.6 shows an example to find the heterogeneous stress 
distribution of fabricated scaffolds.  The scaffold was simulated with 50N of loading 
which caused 1.85% strain deformation.  Although this strain was within the elastic 
region and lower than the 0.2% offset yield strain from the experiment of this scaffold 
(2.53%), the stress on some struts were equal to that of the yield value.  In addition, there 
are some red color regions which indicate tensile stresses on the areas.   
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Fig 3.6 The stress distribution of fabricated 70% porous scaffolds under 50N loading which caused 1.85% 
strain. (a) The stress distribution of the entire scaffold. .(b) The stress distribution of the cross section of the 
white dot line  The blue colors show the high stress region which may cause yield of the scaffold.  (c) Scale 
bar of the stress ranges are -110 MPa (blue) to 50 MPa (red), and the yellow shows around 0MPa stress. 
 
3.4.3.2 Prediction of compressive moduli and yield stresses of designed scaffolds 
The predicted compressive moduli of the 50% and 70% porous scaffold designs 
determined from FE results were 553MPa and 173MPa, respectively.  Further prediction 
of the yield stress can be performed using the relation between applied stress and 
scaffolds maximum stress (Fig 3.7 (a)).  The predictions of the yield stresses were 
determined at the point where the maximum stress of a voxel reaches 110 MPa (bulk 
yield stress from the experiment).  The 50% and 70% porous scaffold designs reached the 
yield stress level when 10.76MPa and 2.94MPa were applied, respectively.   
  
46 
 
 
Fig 3.7 The prediction of the yield stress from the simulation of the scaffold designs, 50% porous scaffold 
and 70% porous scaffold (a). The relation among Weibull fittings, σ and λ (b).   When the scaffold does not 
yield, σ and λ are smaller than the σy and λy.  ε is smaller than εy or equal to 0.  When the scaffold  yields, σ 
and λ are larger than the σy and λy.  ε is bigger than εy. 
 
3.4.3.3 Prediction of moduli and stresses of fabricated scaffolds 
The simulation results show the average modulus of the solid cubes were 2646 ± 36 
MPa (n = 4) and similar to that of the designed cube (2707MPa) and approximately 90% 
of the modulus of compression tests.  The moduli of the fabricated scaffolds were also 
calculated from the FE results and compared with the experimental data (Fig 3.8 (a)).  
Although the simulated values were generally lower than those of the experiments, there 
was a significant correlation between the simulation and the experiments of fabricated 
porous scaffolds (R
2
 = 0.951, y = 1.6557x -44.076).   
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Yield stress of actual fabricated scaffolds was estimated using the modified Weibull 
function fitting.  The Fig 3.7 (b) shows that the relation between the fraction of the voxels 
and their stress levels.  The cumulative fraction of voxels at a given von Mises stress was 
fit well with the modified Weibull distribution.  As applied loads increase, λ, σ and ε 
increase.  When λ is smaller than λy (λ = λL), σ is smaller than σy(σ = σl), and the scaffold 
does not yield.  When λ is bigger than λy (λ = λH), σ is bigger than σy(σ = σH), and the 
scaffold already yields.  ε for yield stress was determined for a von Mises stress of 
110MPa.  Under the yield strain, more than 99% of voxels have a stress level lower than 
the material yield stress (110MPa).  However, the simulation of the higher stress levels 
shows that the curves shift towards a lower fraction and indicate that more voxels are 
exposed to higher stress.  Although various values of ε were applied, plots and linear 
fittings for only the minimum and maximum of ε are shown in Fig 3.8 (b).  For the tested 
ε range, the R2 changed from 0.941 (y = 0.7755x + 0.154) to 0.946 (y = 0.9062x + 
0.4012) with ε = 0.001 the highest which is also shown in Fig 3.8 (b).   
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Fig 3.8 The relations between the simulated moduli and the experimental moduli of the fabricated scaffolds 
(a).  The relations between the simulated yield stresses and the experimental yield stresses of the fabricated 
scaffolds (b).  The green plots and fitting line indicates minimum ε = 0.0001, and the blue plots and line 
shows maximum ε = 0.003.  The red plots and fitting line shows ε = 0.001 with the highest R-square 
(0.946). 
   
3.5 Discussion 
Controlling pore diameter and porosity of the scaffolds is necessary to control 
mechanical properties as well as tissue regeneration and scaffold degradation [37].  We 
successfully fabricated 50:50 PLGA scaffolds with designed strut sizes, pores sizes and 
porosities using IBD and indirect SFF techniques, and those were analyzed using µ-CT 
[43].  The scaffold outer shapes were designed in 7mm cubical shape to mimic the 
trabecular bone samples commonly used to test mechanical properties [51].  To examine 
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the effect of direction of casting on mechanical properties for the same specimen, the 
scaffolds with 1:1 ratio were examined instead of 2:1 ratio in the ASTM standard.  The 
pore sizes of the scaffolds were designed similar or smaller compared to other SFF 
scaffolds for bone application [20,21].  Although the scaffolds have lower porosities, 
50% and 70%, than the conventional scaffolds made by salt leaching and gas forming 
techniques, they have defined orthogonally interconnected pore architectures to allow 
mass transport into the scaffolds.  In addition, lowering scaffold porosity may necessary 
to achieve high mechanical properties since the bulk property of this material is lower 
than bone.        
Solid cubes were fabricated to find the best casting condition for porous scaffolds, and 
to obtain bulk material properties under our manufacturing conditions.  The fabricated 
cubes had high volume fraction, and the bulk moduli and yield stresses which were much 
higher than those of trabecular bone [16,52,53], providing an upper bound on the 
attainable mechanical properties for porous scaffolds.  The anisotropy of the mechanical 
properties may be explained that the fabrication process changed the polymer structures, 
such as crystallinity changes from differential scanning calorimetric tests (data not 
shown).  
From the µ-CT data, it was confirmed that the pores of the 50% and 70 % porous 
scaffolds were orthogonally interconnected and that the molten polymers successfully 
penetrated into the HA secondary mold to form the internal architectures. The pore and 
strut sizes of the fabricated scaffolds were close to the designed ones, but the fabricated 
scaffolds had 8 - 10% lower volume fractions, or higher porosity, than the designed 
values due to some defects or air bubbles trapped inside of the scaffolds.  However, this 
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difference was still smaller than those reported for early applications of direct SFF 
techniques, such as SLA (15-20%) [18].  Indirect SFF scaffolds made of PPF [27] also 
exhibited a larger deviation in volume fraction from designed ones.  Compared with the 
previous scaffolds made by SFF techniques, the fabricated scaffolds had the same or 
better accuracy.  
From the mechanical properties of both the 50% and 70% porous scaffolds, we 
obtained varying scaffold compressive moduli and yield stresses within the range of 
human trabecular bone, whose compressive modulus ranges from 10 to 900 MPa and 
yield stress from 0.2 to 14 MPa [16,52,53].  Our indirect SFF scaffolds also achieved 
higher compressive modulus and yield stress than scaffolds made by previous porogen 
leaching, phase separation and the composite techniques.   In addition, 70% porous 
scaffold showed similar or higher modulus than other direct SFF techniques, such as 20 ~ 
140 MPa of PPF scaffolds [18], 51.6 MPa of blended PCL/PLGA/TCP scaffolds [54] and 
30 ~ 42 MPa of PCL scaffolds [21], although this is in part due to different bulk 
mechanical properties.  The relation between the porosity of scaffolds and the mechanical 
properties showed increasing scaffold volume fraction increased the compressive 
modulus and yield stresses, consistent with other studies [5,11,23].  Furthermore, the 
mechanical properties of porous scaffolds are determined not only by their porosities but 
also by their architectures, including pore sizes and strut thicknesses [18].  Our scaffolds 
were composed with repeating unit cells which have similar diameter and different pore 
and strut sizes, and porosity.   The 50% porous scaffolds had thicker walls than the 70% 
porous scaffolds which determined the mechanical properties depending on scaffold 
design.   
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When fabricating three dimensional porous scaffolds for load bearing applications, it 
is important to that the properties of the fabricated scaffolds match the designed 
properties their designs.  According to the results of our study, there is no a significant 
difference of the compressive modulus or the yield stress among all directions of both the 
70% and 50% porous scaffolds.  These results are different than some of previous studies 
where the scaffolds mechanical properties followed the longitudinal alignments of 
microtubules [36] or a fabrication technique [55].  The anisotropy of their scaffolds relies 
on the design architecture, however, our 50% and 70% porous scaffolds had uniform 
architecture in three directions (X, Y, Z directions), and were not affected by the 
anisotropy of the casting process. 
The files of the designed scaffolds and the µ-CT images of the fabricated scaffolds 
were further converted to simulate the mechanical properties of the fabricated scaffolds.  
The goal of the FE simulation is to predict mechanical properties of scaffolds without 
destroying the scaffolds [20,56].  Although some previous studies performed the 
simulation of designed scaffolds [57,58], these methods could not represent any potential 
manufacturing defects within the fabricated scaffolds.  In addition, other investigators 
used geometry based FEM [45] to simulate scaffold designs, which required significant 
pre-processing time [59].  To solve these limitations, many investigators including our 
own group have used a voxel-based FE method to directly import CT data and 
automatically create voxel meshes [59,60].  Thus, µ-CT and the voxel-based FE analysis 
techniques were adapted in this study to build computer models representing actual 
fabricated scaffolds including defects.  The voxel-based methods are powerful and allow 
simulation of large models in short time compared with a geometry based technique.   
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It is known that linear elements have a stiffer behavior than quadratic elements.  In 
order to get accurate simulation, we used greater than a half million linear voxel elements 
in each model.  In spite of the linear analysis, we applied various loadings to predict yield 
stress since the modified Weibull distribution of modulus is fit to a distribution of 
elements at a given stress, not an absolute value of stress.  Thus, we are looking at the 
number of the elements that have a certain stress level.  This function will not be linear as 
shown in Fig 3.7 (b), since it is the number of elements that exist at a given stress, and 
not the stress in a specific element.  In other words, the number of elements at a given 
stress for a high load may not be linearly proportional to the number of elements at a 
given stress for a low load. 
There have been some concerns that the voxel-based method may possess a certain 
amount of numerical errors inherent to its digitized modeling.  Especially at the boundary, 
there can be oscillations in the responses or local stress concentrations at the stair-like 
boundary.  To evaluate the accuracy of the digital image-based FE method, Guldberg et 
al., [61] compared voxel-based solutions to analytical solutions and showed that the error 
was less than 5% if a structural member is modeled with 10 voxel elements. They also 
confirmed oscillatory behavior of the stresses in the voxel-based solution; however, the 
oscillation was around the exact solution, which allowed filtering technique to minimize 
the errors.  In this study, the smallest strut size of the scaffolds was about 300µm, and the 
voxel size was 30µm.  The beam diameter to voxel ratio is 10, which indicates the error is 
small enough to be negligible, and the stress concentration was minimized in the 
simulation by averaging stress values [61].   
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We first performed the stress distributions and the scaffolds deformations under 
compression.  Combining the bulk mechanical properties of 50:50 PLGA, the FE analysis 
could also be used to predict potential yield stress of the designed scaffolds.  Although 
the simulation results of the designed scaffolds showed homogeneous stress distribution 
patterns, the stress distributions of the fabricated scaffolds were heterogeneous and 
showed tensile stresses besides compression stresses due to defects.   
The predicted compressive moduli of the designed scaffolds were greater than the 
experimental compressive moduli of the fabricated scaffolds because the designed 
scaffolds do not contain any defects.  Experimental scaffolds were mechanically inferior 
to the computational image based designs due to defects in the actual material such as 
microcracks, voids and rough layer boundaries.  Using FE models alone based on a 
perfect design without defects can leads to overestimates of mechanical properties.  
To achieve a more accurate prediction of scaffolds mechanical properties, the unique 
approach of combining post-fabrication imaging (µ-CT) and finite element analysis 
(Voxel FEM) was performed.  This approach allows captured significant portion of the 
material defects in the computational model.  Comparison between the experimental 
values and predicted values proved that our computational analysis correlated well with 
our experimental data.  By introducing ε, a small fraction of voxels were allowed to 
undergo stresses higher than bulk yield even at the ultimate load.  A fabricated porous 
scaffold may not suffer overall yielding even if it experiences local yield stress. We 
found that variation of ε causes a variation of the correlation, which implies that there 
may be an optimal value of ε to detect yield loads of the fabricated scaffolds, and further 
experiments are needed to find the optimal value.  Our results showed that simulation 
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using the µ-CT data had better correlation than the designed scaffolds.  Although ideally 
one would look for a 1 to 1 correlation between computational and experimental results, 
finding a significant correlation between their results is still very helpful for design 
purposes, especially if the correlation is conservative.  Such a correlation would allow 
engineers to computationally predict how variations in architecture can affect elastic 
modulus and yield stress and rapidly examine a large range of architectural designs to 
determine a range of desired properties that would not be feasible using a purely 
experimental approach. 
Limitations of our fabrication method are defects in the final product from the 
fabrication process, which include air bubbles and residual hydroxyapatite.  Although we 
successfully fabricated solid cubes, there was unavoidable air rapped during casting of 
the polymer into the HA secondary molds [24], where molten PLGA was cast into the 
HA secondary molds.  In addition, during decalcification of HA, PLGA may suffer some 
degradation due to the acidic solution of the RDO.  These limitations may be minimized 
by modifying the design of the secondary molds or the decalcification method.  
The difference between the simulations and the experiments may be explained by 
several factors during processing of images were processed from µ-CT to FE software.  
Since the grayscale images of the CT data included some noise and did not show clear 
boundaries of the scaffolds, some details of the scaffolds may be lost when they were 
exported to stl files.  In addition, the resolutions of the original CT images were reduced 
due to the memory limitation of the FE software and the computer as well as the voxel 
representation that may lose some details of the scaffolds shapes.  The actual material 
moduli of the base material that makes the scaffolds may be lower than the moduli input 
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for the base material in the FE model, perhaps due to some degradation of polymer 
material by the RDO acid.  
 
3.6 Conclusions 
It was demonstrated that indirect SFF technique can be used to fabricate designed 
scaffolds with interconnected porous architectures directly from image-based design 
techniques.  These fabricated scaffolds could attain moduli and strength values in the 
range of human trabecular bone.  Moreover, µ-CT structural measurements of 50:50 
PLGA porous scaffolds showed scaffolds had consistent reliable volume fraction similar 
to designed volume fraction although some casting defects are still present.  Thus, 
measured scaffold modulus and yield stress within trabecular bone range demonstrates 
that highly porous interconnected scaffolds can be fabricated with load bearing capacity.  
The mechanical properties of the scaffolds were also simulated using voxel-based finite 
element methods and the result showed strong correlations between the experiments and 
simulations for both compressive modulus and yield strength.  The use of this 
nondestructive method to predict modulus and yield stress will allow rapid and rigorous 
evaluation of scaffold mechanical quality for in vivo applications.  With further 
experimental validation more rigorous prediction may be possible.   
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CHAPTER 4 
Effects of Designed PLLA and 50:50PLGA Scaffold Architectures on Bone 
Formation In Vivo 
 
4.1 Abstract 
Biodegradable porous scaffolds have been investigated as an alternative approach to 
current metal, ceramic, and polymer bone graft substitutes for lost or damaged bone 
tissues.  Although there have been many studies investigating the effects of scaffold 
architecture on bone formation, many of these scaffolds were fabricated using 
conventional methods, such as salt leaching and phase separation, and were constructed 
without designed architecture.  To study the effects of both designed architecture and 
material on bone formation, we designed and fabricated three types of porous scaffold 
architecture from two biodegradable materials, poly (L-lactic acid) (PLLA) and 
50:50Poly (lactic-co-glycolic acid) (PLGA) using image based design and indirect solid 
freeform fabrication techniques, seeded them with bone morphogenic protein-7 
transduced human gingival fibroblasts and implanted them subcutaneously into mice for 
4 and 8 weeks.  Micro-computed tomography data confirmed that the fabricated porous 
scaffolds replicated the designed architectures.  Histological analysis revealed that the 
50:50PLGA scaffolds degraded and did not maintain their architecture after 4 weeks.  
The PLLA scaffolds maintained their architecture at both time points and showed 
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improved bone ingrowth which followed the internal architecture of the scaffolds.  
Mechanical properties of both PLLA and 50:50PLGA scaffolds decreased, but PLLA 
scaffolds maintained greater mechanical properties than 50:50PLGA after implantation.  
The increase of mineralized tissue helped to support mechanical properties of bone tissue 
and scaffold constructs from 4 to 8 weeks.  The results indicated the importance of choice 
of scaffold materials and computationally designed scaffolds to control tissue formation 
and mechanical properties for desired bone tissue regeneration. 
 
4.2 Introduction 
Bone graft substitutes such as titanium and other metals have been used for 
reconstructing bone defects caused by injury, inflammatory disease or cancer.  However, 
these implants are less than ideal because the materials are non-degradable and may 
cause stress shielding.  Tissue engineered scaffolds have been studied as alternative 
implants to heal skeletal defects.  To enhance bone tissue integration and bone growth 
into the tissue engineered scaffolds, the scaffolds should have porous architecture to 
encourage cell migration and blood vessel formation [1].  It is also necessary to have 
sufficient mechanical properties to support physiologic loading, and proper degradation 
profiles to transfer loads to regenerating tissues during healing [2-4].   
Poly (L-lactic acid) (PLLA) and Poly (lactic-co-glycolic acid) (PLGA) have both been 
approved by the FDA for specific clinical indications [5].  They have been used as 
orthopaedic implants [2,6] and have been widely studied as scaffolds for bone 
regeneration both in vitro and in vivo.  Due to different degrees of hydrophilicity, 
degradation ratios and by-products, PLLA and PLGA have different effects on cell 
  
62 
 
behavior and tissue regeneration, and have been compared in different matrices, 
including films, porous sponges, and fiber like shapes using various cell types [7-10].  It 
has been demonstrated that the degradation time changes depending on the ratio of lactic 
acid and glycolic acid polymer [8,9,11].  Thus, adjusting the polymer ratio should control 
the degradation time of these scaffolds and their distinct degradation profiles may 
influence bone regeneration. 
In addition to the scaffold material composition, factors influencing scaffold 
architecture, such as porosity and pore size, play a critical role in cell migration and bone 
formation into the scaffolds [12,13].  It has been postulated that an approximately 100 
µm pore diameter is suitable for in vitro cell migration and a 300 µm pore diameter is 
necessary for tissue ingrowth and nutrient diffusion [1,14].  However, the effects of 
scaffold architecture on bone tissue formation are not fully known, and vary significantly 
between studies [15-22].  Because the effects of scaffold architecture on bone formation 
may differ depending on the materials studied [22,23] and the ability to fabricate 
scaffolds with controlled pore architectures [24], it is necessary to investigate the effects 
of rigorously controlled architectures for each biodegradable scaffold to clearly delineate 
architecture versus material influence on bone regeneration.  
Conventional biodegradable scaffolds, especially scaffolds made from PLLA and 
PLGA, have been commonly fabricated by salt leaching or gas foaming and have a wide 
range of pore sizes with poor or non-interconnected pores, and the scaffold architectures 
are not identically duplicated with repeated samples [25,26].  It is also difficult to control 
local pore and wall locations, and porosities of these scaffolds.  Currently, scaffold 
architecture is controlled in the global or overall scaffold level.  Furthermore, in order to 
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ensure pore interconnectivity, porosity needs to be increased, and as a result the 
mechanical properties of scaffolds may thus be reduced [27].   
To overcome these limitations, the combination of computer aided design and solid 
freeform fabrication techniques have been developed [4,28-30].  These methods allow 
design and fabrication of scaffolds with controllable local pore architecture to generate 
reproducible and effective mechanical and mass transport properties.  Our group has 
developed image based design techniques by which the internal architectures of scaffolds 
can be customized based on the mathematical concept of unit cells [31-33].  These unit 
cells are designed and fabricated to have the desired effective physical properties, such as 
compressive modulus, permeability and diffusivity.  Furthermore, we have utilized the 
indirect solid freeform fabrication (SFF) method to fabricate scaffolds with designed pore 
diameters, struts sizes and porosities [34].  Utilizing these techniques, we have 
successfully designed and fabricated 50:50PLGA porous scaffolds which have 
compression moduli within the range of human trabecular bone [35]. 
Bone morphogenetic proteins (BMPs) belong to the TGF-β family and had been 
extensively applied using direct BMP delivery or in vivo or ex vivo delivery via gene 
therapy to induce bone formation for skeletal regeneration [36-38].  Our method to 
express BMPs in vivo uses human dermal and gingival fibroblasts that have been 
transduced by recombinant adenovirus encoding BMPs to induce bone formation in 
ectopic sites [39,40].  This technique has also been combined with porous SFF scaffolds 
to facilitate bone generation [15,41-43].  Consequently, this ex vivo gene therapy method 
can be applied to induce bone formation in our engineered scaffolds. 
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The goal of this study was to determine the influence of scaffold material and 
architecture, especially pore size, strut size and surface/volume ratio on bone formation in 
vivo and to evaluate the mechanical properties of the resulting scaffolds and tissue 
constructs.  Six groups of scaffolds, (three different designs and two different materials, 
PLLA  and 50:50PLGA scaffolds) were fabricated. These scaffolds were seeded with 
transduced human gingival fibroblasts expressing BMP-7, and then implanted into mice 
subcutaneous pockets for 4 and 8 weeks.  The scaffolds and scaffold/regenerated bone 
tissue construct were evaluated using Micro-computed tomography (μ-CT), mechanical 
testing, and histological assessments. 
 
4.3 Methods 
4.3.1. Porous Scaffold Design and Fabrication  
Porous scaffolds 5mm in diameter and 3mm high with three different pore diameters 
(280, 550, and 820µm) were designed using image-based techniques (Fig 4.1, a).  Based 
on the designed pore sizes, each group of the scaffolds was named Large (pore size = 
820µm), Medium (pore size = 550µm), or Small (pore size = 280µm).  First, the unit 
cells of each design were determined, and then, generated in a repeating pattern to fill the 
external scaffold geometry.  The resulting image representations were converted to 
stereolithography (STL) formats and sliced in the Modelworks software (Solidscape, Inc., 
Merrimack, NH) to fabricate wax molds using a ModelMaker II (for Large and Medium) 
or PatternMaster  (Fig 4.1, b) (for Small) 3D printer (Solidscape, Inc., Merrimack, NH).  
These wax molds (Fig 4.1, c) were cast into hydroxyapatite ceramic (HA) secondary 
molds (Fig 4.1, d). Polymer pellets, PLLA (Inherent Viscosity = 0.65dL/g) and 
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50:50PLGA (Inherent Viscosity = 0.61dL/g) (Birmingham Polymers Inc., AL), were 
heated at 205ºC and 170 ºC, respectively, in a Teflon mold.  The HA molds were then 
placed into the Teflon mold containing molten polymer, in order to force the polymer 
through the open pore network.  The HA molds were then removed from the porous 
polymer scaffolds using RDO Rapid Decalcifier (APEX Engineering Products Corp, 
Plainfield, IL).  The scaffolds were sterilized in 70% ethanol overnight and then left in 
100% ethanol until the day of implantation.   
 
Fig 4.1 Porous scaffolds were designed using image based design techniques and exported into STL 
formats (Large, Medium and Small, from left to right) (a). The stl format files were imported to the rapid 
prototyping machines (b) to print the thermoplastic molds (c).  The thermoplastic molds were casted into 
HA secondary molds (b), and finally the HA secondary molds were casted into either PLLA scaffolds (e) or 
50:50PLGA scaffolds (f). 
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4.3.2. Cell preparation and scaffold implantation       
Primary human gingival fibroblasts (HGFs) were prepared from explants of human 
surgical waste in compliance with the University of Michigan Institutional Review Board 
[39].  HGFs from passage 5- 10 were cultured near confluence in Alpha minimum 
essential medium (α-MEM) supplemented with 10% fetal bovine serum, and 1% 
penicillin and streptomycin (Gibco).  24 hours before implantation, the HGFs were 
infected with AdCMV-BMP-7, a recombinant adenovirus construct expressing murine 
BMP-7 gene under a cytomegalovirus (CMV) promoter, at a multiplicity of infection 
(MOI) of 1000 PFU/cell [44].  Two million cells were seeded into each scaffold by 
suspending them in 60µl of 5mg/ml bovine plasma-derived fibrinogen (Sigma), and 
gelled with 6µl of 100U/ml bovine plasma-derived thrombin (Sigma).  The scaffolds 
seeded with 2 million cells were subcutaneously implanted into immunocompromised 
mice (N: NIH-bg-nu-xid, Charles River, Wilmington, MA).  After animals were 
anesthetized with an injection of ketamine/xylazine, 4 subcutaneous pockets were created 
and 4 scaffolds were implanted into each mouse, and finally surgical sites were closed 
with wound clips in compliance with University Committee on Use and Care of Animal 
(UCUCA) regulations.  The mice were sacrificed at 4 and 8 weeks after the implantation, 
and the scaffold and tissue constructs were harvested, fixed with Z-fix (Anatech, Battle 
Creek, MI) and left in 70% ethanol for further assay. 
 
4.3.3. Assay of scaffolds and regenerated tissues  
All of the scaffolds pre-implantation alone and post-implantation with tissues were 
scanned using a MS-130 high resolution µ-CT Scanner (GE Medical Systems, Toronto, 
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CAN) at a resolution of 16 m. The scanned images were reconstructed using 
MicroView software (GE Healthcare).  The reconstructed images were used to calculate 
the scaffold pore size, porosity and surface area prior to implantation and Bone volume 
(BV) and Tissue mineral density (TMD) were calculated for the scaffolds after 
implantation.  The surfaces of pre-implanted scaffolds were also examined under a 
scanning electron microscope (XL30 ESEM, Philips).  The environmental scanning 
electron microscopy (ESEM) mode was carried out at10kV and in a humid atmosphere of 
0.7 Torr.  
 
4.3.4. Mechanical test of scaffolds with regenerated tissue 
Following µ-CT scanning, 4-7 replicates from each scaffold group were mechanically 
tested.  Compression tests were performed after scaffolds were rehydrated for 30 minutes, 
using a MTS Alliance RT30 Electromechanical test frame (MTS Systems Corp., MN).  
The cross head speed was 1mm/min after a preload of 0.227kg (0.5 lbs) for PLLA 
scaffolds and 0.0227kg (0.05 lbs) for 50:50PLGA scaffolds.  The heights of the scaffolds 
were measured with a caliper, and the TestWorks4 software (MTS Systems Corp., MN) 
was used to record load and displacement data.  The stress-strain curves were calculated 
from the initial dimensions of specimens.  The compressive modulus was defined by the 
slope at the initial linear section of the stress-strain curve.    
 
4.3.5. Histological analysis 
After scanning with the µ-CT machine, one harvested scaffold from each group was 
also used for histological assay.  The scaffold and tissue constructs were demineralized 
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with RDO and the residual polymer in the tissue was removed using chloroform prior to 
paraffin-embedding. The scaffolds were then sectioned at 5 µm and stained with 
hematoxylin and eosin (H&E). 
 
4.3.6. Statistical analysis 
The statistical analysis was performed with SPSS (SPSS, Inc., Chicago, IL USA).  
Two groups were analyzed with Student’s t-test for independent samples. Multiple 
comparison procedures were determined by one-way ANOVA followed by Tukey’s Post 
Hoc multiple comparisons.  Errors are reported in figures as the standard deviation (SD) 
and significance was determined using probability value of p < 0.05.  
 
4.4 Results 
4.4.1. Evaluation of the fabricated (pre-implanted) scaffolds 
The schematics of the design and fabrication process of the scaffolds are depicted in 
Fig 4.1.  HA secondary molds (Fig 4.1, d) ensured the fabrication process was identical 
between PLLA and 50:50PLGA scaffolds except for polymer casting temperatures.  The 
architecture of the designs was the same for both the fabricated PLLA and 50:50PLGA 
scaffolds (Fig 4.1, e, f), which was also confirmed by µ-CT rendering images (Fig 4.2, a-
f).  The orthogonal pore locations and connections of the fabricated PLLA and 
50:50PLGA scaffolds were also confirmed from the cross sectional images of µ-CT data 
(Fig 4.2, g-l).  Low magnification ESEM images were similar in all groups (Fig 4.2, m-r), 
while the high magnification images showed slightly rougher surfaces on the PLLA 
scaffolds than the 50:50PLGA scaffolds (Fig 4.2, s-x, indicated by stars).  Furthermore, 
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porosity, surface to volume ratio, pore sizes and strut sizes were measured using the µ-
CT images (Table 4.1).  For each parameter, there was no significant difference between 
the fabricated PLLA and 50:50PLGA scaffolds. These data support the concept that the 
scaffold architectures within each design group (Large, Medium, and Small) made of the 
two materials are identical to each other.  Porosity, pore size and strut size of the 
fabricated scaffolds decreased in order from Large to Small pore designs. The Small 
group had a higher surface to volume ratio than the Large and Medium group for both 
PLLA and 50:50PLGA scaffolds.  
    
 
Fig 4.2 µ-CT rendering images (a-f), µ-CT images showing cross sectional x, y, and z planes (g-l), and 
ESEM images of fabricated PLLA and 50:50PLGA scaffolds (m-x).  The scale bars in the ESEM images 
are 1mm and 200 µm for Low (m-r) and High magnifications (s-x), respectively. * indicates the surface 
around the pores for comparison of the surface morphologies of PLLA and 50:50PLGA scaffolds. 
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Table 4.1 Fabricated scaffold dimensions 
 
 
Large 
PLLA 
Medium 
 
Small 
 
Large 
50:50PLGA 
Medium 
 
Small 
Pore size (mm) 0.821 ± 0.041 0.580 ± 0.039 0.285 ± 0.026 0.840 ± 0.057 0.537 ± 0.033 0.258 ± 0.037 
Strut size (mm) 0.914 ± 0.028 0.594 ± 0.033 0.413 ± 0.017 0.898 ± 0.045 0.622 ± 0.050 0.448 ± 0.039 
Porosity (%) 52.1 ± 0.95 45.4 ± 3.21 32.1 ± 3.50 52.9 ± 2.17 43.8 ± 2.21 30.5 ± 3.30 
Surface/Volume  
(mm2/ mm3) 
4.57 ± 0.22 4.54 ± 0.15 5.40 ± 0.17 4.65 ± 0.25 4.88 ± 0.31 5.43 ± 0.59 
 
4.4.2. Histological observations of implanted scaffolds 
Due to the secretion of BMP-7 from the transduced HGFs, all of the implanted 
scaffolds had bone-like tissue formation after 4 and 8 weeks (Fig 4.3).  The histological 
images show cortical bone-like tissues formed outer layers and bone marrow-like tissues, 
such as trabecular structures, endothelial cells and osteoblasts, were observed within the 
cortical layer and the scaffolds.  In the 4 week implant groups, most of the marrow-like 
tissues were distributed in the peripheral regions of the specimen.   However, more bone 
marrow-like tissues containing blood vessel-like tissues were observed in the 8 week 
implants than in the 4 week implants.  We found marrow- like tissue both at the center of 
the scaffolds and also in the surrounding regions at 8 weeks.   
The histological images also show that tissue formation differed between PLLA and 
50:50PLGA scaffold groups.  After 4 weeks of implantation, little degradation of PLLA 
was observed, and most of their architectures remained intact (Fig 4.3, a-c).  However, 
50:50PLGA scaffolds degraded more rapidly and lost their initial architectures (Fig 4.3, 
d-f).  After 8 weeks of implantation, PLLA scaffolds maintained their architecture, while 
most of 50:50PLGA degraded, leaving very little polymer, and the bone constructs 
appeared flattened (Fig 4.3, h-m).  After degradation of most of the 50:50PLGA scaffolds, 
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the histological images showed more bone marrow-like tissues containing blood vessel-
like tissues in 8 week implants than in 4 week implants.  For PLLA scaffolds, bone-like 
tissues formed mostly in the peripheral area of the scaffolds and very little bone ingrowth 
was observed (Fig 4.3, a-c, and g), and a few blood vessel-like tissues were seen inside of 
the scaffolds (Fig 4.3, g) at 4 weeks.  At 8 weeks, advanced bone ingrowth was observed 
following the porous architectures of the Small PLLA scaffolds (Fig 4.3, j), and larger 
blood vessel tissues were also observed (Fig 4.3, n).  In addition, there may be more 
fibrous tissue on PLLA scaffolds at 4 weeks than 8 weeks. 
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Fig 4.3 Histological images of PLLA (a, b, and c) and 50:50PLGA scaffolds (d, e, and f) at 4 weeks and 
PLLA (h,i and j) and 50:50PLGA scaffolds (k, l, and m) at 8 weeks. Porous architectures of PLLA 
scaffolds were maintained for all groups (a, b, and c) at 4 weeks and (h, i, and j) at 8 weeks.  None of 
50:50PLGA groups maintained the initial architectures, however, polymer material was still left inside of 
the bony shells at 4 weeks (d, e, and f).  After 8 weeks, most of 50:50PLGA polymer had degraded and 
disappeared (k, l, and m).  Magnified areas of Small PLLA scaffold at 4 weeks (c) were shown (h: dashed-
dotted line).  Yellow arrow indicates fibrous tissue between scaffold and trabecular like tissue, and a few 
blood vessel-like tissues were indicated by blue arrows (g).  Magnified areas of Small PLLA scaffold at 8 
weeks (j) were also shown (n: dashed-dotted line).  Thicker blood vessel-like tissues were observed within 
the scaffold pores, shown by blue arrows (n). 
 
4.4.3. Tissue observations using µ-CT 
Three dimensional tissue representations were generated from µ-CT data (Fig 4.4).  
Mineralized tissues were highlighted, and color contours indicated the density of the 
regenerated tissues.  Highly dense tissues were distributed only on the outside of the 
scaffolds.  Due to the rapid degradation, there was no bone growth into the 50:50PLGA 
scaffolds.  All PLLA scaffolds maintained their architectures at all time points.  There 
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was some bone ingrowth into the PLLA scaffolds at 4 weeks, while there was slightly 
more bone ingrowth at 8 weeks.  Maximum bone penetration was measured as the 
distance from the circular peripheral edge of each scaffold towards the center (N = 3-5 
scaffolds).  The bone penetration in the Small , Medium and Large PLLA scaffolds was 
0.464 ± 0.024 mm, 0.723 ± 0.392 mm, and 0.457 ± 0.146 mm, respectively at 4 weeks, 
and 1.043 ± 0.292 mm, 0.834 ± 0.249 mm, and 0.773 ± 0.049 mm, respectively at 8 
weeks.  Small PLLA scaffolds supported a significant increase of bone penetration from 
4 to 8 weeks.  Large and Medium PLLA scaffolds also had increases in bone penetration, 
but these did not reach a statistically significant level. There was no significant difference 
between the scaffold groups at each time point.  Also, the pattern of bone ingrowth 
followed the internal scaffold architectures, and bone tissues regenerated along the struts 
(Fig 4.4, g-i).  More bone tissue distribution was observed at 8 weeks than at 4 weeks 
with the highest amounts seen in the Small PLLA group, which had more bone 
surrounding the struts (Fig 4.4, i). 
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Fig 4.4 µ-CT images of PLLA (a, b, and c) and 50:50PLGA scaffolds (d, e, and f) at 4 weeks, and PLLA (g, 
h, and i) and 50:50PLGA scaffolds (j, k, and l) at 8 weeks. Some struts were surrounded by tissues are 
indicated by *.  Relative density of the tissues are indicated with color scale (m) 
       
4.4.4. Tissue mineral density and bone volume of implanted scaffolds 
TMD and BV were also calculated using µ-CT data (Fig 4.5, Table 4.2).  The data 
demonstrated that TMD significantly increased in all groups from 4 week implantation to 
8 weeks.  From the 4 week implantation data, although there was no significant 
difference, the Small PLLA scaffold group had higher TMD than the Large and Medium 
PLLA scaffold groups (Fig 4.5, a).  In addition, Large and Medium 50:50PLGA scaffold 
groups had more mineralized tissues than the Large and Medium of PLLA scaffold 
groups at 4 weeks (no significant difference).  Medium and Small PLLA scaffold groups 
showed slightly higher mineral density than Medium and Small 50:50PLGA scaffold 
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groups (Fig 4.5, b).  The results of TMD were similar in all groups at both time points, 
while BV results showed different trends depending on the scaffold materials.  Although 
only the Large 50:50PLGA showed a significant difference (Fig 4.5, c, d), the trends 
suggested that PLLA scaffolds lost their BV from 4 weeks to 8 weeks time points, while, 
50:50PLGA increased BV during that time.  In addition, other trends showed that PLLA 
scaffolds had more BV than 50:50PLGA scaffolds at the 4 weeks time point (Fig 4.5, c), 
however, after 8 weeks implantation, 50:50PLGA scaffolds showed higher BV (Fig 4.5, 
d) (no significant difference).   
 
Fig 4.5 Tissue mineral density (TMD) at 4 (a) and 8 (b) weeks, and Bone volume (BV) at 4 (c) and 8 (d) 
weeks.  There was no significant difference of TMD and BV values between PLLA and 50:50PLGA 
scaffolds.  
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Table 4.2 Tissue Mineral Density, Bone Volume and Modulus of scaffold and tissue constructs at 4 and 8 
weeks 
   PLLA   50:50PLGA  
  Large Medium Small Large Medium Small 
TMD 
(mg/cc) 
4 wk 462.6 ± 12.4 
(N=4) 
463.4 ± 12.5 
(N=5) 
482.4 ± 12.1 
(N=5) 
482.8 ± 14.0 
(N=8) 
477.5 ± 21.7 
(N=7) 
476.2 ± 16.4 
(N=5) 
8 wk 524.8 ± 21.4 
(N=3) 
546.0 ± 14.7 
(N=5) 
536.5 ± 24.4 
(N=5) 
534.5 ± 31.4 
(N=5) 
519.9 ± 22.5 
(N=5) 
528.7 ± 29.2 
(N=5) 
Bone 
Volume 
(mm3) 
4 wk 13.96 ± 5.14 
(N=4) 
17.37 ± 6.53 
(N=5) 
18.66 ± 13.87 
(N=5) 
8.58 ± 2.08 
(N=8) 
11.61 ± 3.28 
(N=7) 
10.39 ± 2.27 
(N=5) 
8 wk 9.83 ± 0.89 
(N=3) 
11.25 ± 3.85 
(N=5) 
14.71 ± 4.28 
(N=5) 
13.88 ± 4.76 
(N=5) 
15.55 ± 4.38 
(N=5) 
21.77 ± 11.96 
(N=5) 
Modulus 
(MPa) 
0 wk 100.4 ± 56.4 
(N=7) 
98.9 ± 30.6 
(N=7) 
196.4  ± 76.7 
(N=7) 
197.8  ± 53.7 
(N=6) 
239.0  ± 102.6 
(N=6) 
125.1  ± 63.2 
(N=5) 
4 wk 13.0 ± 4.2 
(N=4) 
29.4 ± 14.2 
(N=4) 
90.5 ± 41.7 
(N=7) 
0.78 ± 0.35 
(N=5) 
1.30 ± 0.73 
(N=6) 
0.80 ± 0.40 
(N=4) 
8 wk 32.2 ± 31.9 
(N=3) 
53.7 ± 28.1 
(N=5) 
83.4 ± 27.3 
(N=5) 
5.43 ± 5.97 
(N=5) 
4.15 ± 1.79 
(N=4) 
6.62 ± 3.52 
(N=4) 
 
4.4.5. Mechanical properties    
A compressive test was performed to investigate the changes in scaffold mechanical 
properties during implantation (Fig 4.6, a,d).  The average mechanical properties of 
PLLA and 50:50PLGA scaffolds were equal to or greater than 100 MPa prior to 
implantation.  All PLLA scaffolds had significantly decreased mechanical properties after 
4 weeks of implantation due to polymer degradation (Fig 4.6, a).  Then, their mechanical 
properties were increased or maintained after 8 weeks implantation due to growth of 
mineralized tissues.  All 50:50PLGA scaffolds had nearly a complete loss of mechanical 
properties at 4 weeks, but then slightly increased after 8 weeks of implantation (Fig 4.6, 
b).  The mechanical properties of all of the 50:50PLGA scaffolds were significantly 
lower than Small PLLA scaffolds at 4 weeks and Medium and Small PLLA scaffolds at 8 
weeks. 
The correlation between the modulus and bone volume are shown in Fig 4.6 (b, c, e, f).  
PLLA scaffolds did not have any correlation at 4 (R
2
 = 0.0371) and 8 (R
2
 = 0.0102) 
weeks. However, 50:50PLGA scaffolds had some correlation at 4 (R
2
 = 0.4809) and 8 
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(R
2
 = 0.4043) weeks.  The 8 week data had an outlier which lowered the correlation, 
which increased to R
2
 = 0.8884 without the outlier.  These results indicate that increased 
bone deposition increased the moduli of the regenerated tissues when the scaffold 
modulus was significantly reduced.  
 
Fig 4.6 Mechanical test results of implanted PLLA (a) and 50:50PLGA (d). * indicates significant 
difference.  Correlations between modulus and bone volume of PLLA scaffolds at 4 (b) and 8 (c) weeks 
and 50:50PLGA scaffolds at 4 (e) and 8 (f) weeks. R-square values are 0.0371 (b), 0.0102 (c), 0.4809 (e) 
and 0.4043 (f).  The value of (f) increases to 0.8884 without the outlier (indicated with an arrow). 
 
4.5 Discussion 
Computer based scaffold design and SFF were used to determine the effect of porous 
scaffold material and architecture on bone regeneration.  PLLA and 50:50PLGA 
scaffolds were fabricated using the identical procedure with the exception of their melting 
temperatures.  The semi-crystalline structure of PLLA required a higher casting 
temperature, while the 50:50PLGA can be melted at a lower temperature than PLLA due 
to its amorphous structure.  The μ-CT data demonstrated that the fabricated PLLA and 
50:50PLGA scaffolds had similar defined pore sizes, strut sizes, porosities and surface to 
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volume ratios.  In addition, the μ-CT results verified that the fabricated scaffolds in the 
same design groups had identical internal and external architectures between materials.  
Although the viscosities of the polymers were similar, the surface morphologies of the 
scaffolds were slightly different as shown in the ESEM images.  This may be due to the 
difference of the chemical structures including crystallinity of the polymers. 
Ex vivo gene therapy was used to induce bone formation from the surrounding tissues at 
the implant site.  This regenerative gene therapy strategy using adenoviral vectors can be 
applied to transduce various cells, such as bone marrow stromal cells [45], and fibroblasts 
[40,46].  The consistent secretion of BMP-2 from adenovirus transduced HGFs up to 2 
weeks in vitro has been reported [47].  Additionally, this approach has been studied to 
induce endochondral-like bone tissue formation by transduced HGFs [40,48].  Other 
methods of bone formation have previously been reported, including seeding bone 
marrow stromal cells [49], incorporation of BMP-7 into nanospheres [50], and BMP-2 
conjugated with heparin [49].  However, these methods require pre-treatment of the 
scaffolds prior to implantation.  The scaffolds may start degrading during the preparation, 
especially 50:50PLGA scaffolds due to their short degradation profile.  Therefore, to 
minimize any alteration of the scaffolds before implantation and successfully regenerate 
bone tissue in vivo, ex vivo gene therapy was a suitable method for testing this study.  
Scaffold tissue constructs differed between the PLLA and 50:50PLGA scaffolds due 
to polymer degradation.  PLLA scaffolds maintained their architecture throughout the 
study period, while 50:50PLGA scaffolds completely lost the original designed pore 
structure, and there were only chunks remaining at the 4 week time point.  The 
hydrophilicity of the PGA component in PLGA may induce faster water uptake and 
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hydrolysis leading to faster degradation [11].  In contrast, the methyl group of the PLLA 
side chain contributes to the hydrophobicity of the polymer, resulting in slower 
degradation [10].  As reported previously, the in vivo half-life of 50:50PLGA foams was 
about 2 weeks [11], our 50:50PLGA scaffolds may maintain their architectures for only a 
few weeks or less in vivo.   
Due to the rapid degradation, little bone tissue was found inside the degraded 
50:50PLGA scaffolds at 4 and 8 weeks.  In contrast, the PLLA scaffolds had small 
amounts of bone ingrowth and some blood vessel-like tissues from the histological 
analysis.  These differences may be attributed to the effects of degradation by-products 
on cell activities.  PLLA nanofibers or porous membranes supported activities of 
chondrocytes and human mesenchymal stem cells and vascularization more than those of 
50:50PLGA since rapid degradation of 50:50PLGA created acidic environments and 
prevented cell activities on or in the constructs [8,9].  In addition, reduction of pH 
negatively affected activities of bone marrow stromal cells during osteogenesis [51].  
Although there are no data regarding pH change or acidic by-products in this study, there 
may be similar effects on cell activities and tissue formation for both the PLLA and 
50:50PLGA scaffolds at the earlier time point.  Additionally, the collapse of the PLGA 
porous architecture would prohibit cell migration and bone formation within the scaffold 
interior.    
The trends of BV results show that BV was higher on the PLLA scaffolds than the 
50:50PLGA scaffolds at 4 weeks, while the 50:50PLGA scaffolds had higher BV at 8 
weeks.  The acidic environment may also explain the change in bone volume over time.  
Initially, at 4 weeks, bone formation was inhibited by more acidic by-products in the 
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environment on the PLGA scaffolds, but, the removal of these degradation by-products 
allowed restoration of cellular activities which may have led to the bone volume increase 
observed at the 8 week time point.  The PLLA scaffolds may have more degradation by-
products which may lower BV at 8 weeks.  From the data shown in this and previous 
studies [8,9,51], PLLA scaffolds may be more useful in this situation because it has a 
slower degradation rate that allows new tissue to generate while it still maintaining 
sufficient mechanical properties to support new tissue growth.  In comparison, the 
50:50PLGA is not able to support the tissue due to its fast degradation profile.  It would 
be useful to study another polymer, such as 85:15PLGA that lasts longer in vivo, as SFF 
scaffolds for bone application. Furthermore, the effects of SFF scaffolds on degradation 
need to be investigated to better understand the interaction between scaffolds and tissue 
formation. 
The PLLA scaffolds in this study showed much less bone ingrowth than porous HA 
scaffolds and porous poly (propylene fumerate)/tricalcium phosphate (PPF/TCP) 
scaffolds reported in our previous studies [15,42] since HA and TCP are known 
osteoconductive materials that have been shown to allow chemotactic adherence for 
enhanced bone growth.  Furthermore, hydrophobic materials, like PLLA, may delay cell 
attachment and bone formation [52,53].  In addition, the layers of tissues or bony shell 
surrounding the PLLA scaffolds prevent diffusion of nutrients into the construct [54] and 
may cause accumulation of acidic by-product inside of the implants, which could prohibit 
cell migration and tissue ingrowth.   
The importance of scaffolds pore sizes for bone formation has been discussed in many 
studies.  The minimum pore size, 280 µm, in this study was chosen based on the required 
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diameters for blood vessel formation, which was approximated according to in vivo bone 
tissue formation in previous studies [19,52,55].  Although the effect of pore size of PLLA 
or PLGA porous scaffolds on bone regeneration has been explored in various studies, 
these results varied depending on the materials and methods of the study.  For example, 
pore sizes of PLGA scaffolds did not affect osteoblast activities in vitro nor was in vivo 
bone formation influenced by pore sizes within the range of 150-710 µm and 125-500 µm 
[20-22].  In contrast, another group compared porous PLGA scaffolds with constant 
porosity and indicated that pore size between 400 and 600 µm were favorable for 
osteoblasts rather than 300 µm or smaller pore sizes [56,57].  Another study 
demonstrated that PLLA scaffolds with pores of 350 µm diameters induced more bone 
ingrowth than the smaller ones (100 and 200 µm) when implanted in rabbits’ calvarias 
[58].  However, it is again critical to note that these previous studies, which suggested an 
influence of pore diameter [56-58], utilized conventional fabrication techniques which 
did not rigorously control pore diameter and interconnectivity.  Our chosen pore size, 280, 
550 and 820 µm, thus bracketed the range of pore sizes investigated in previous studies: 
with the difference being the controlled interconnected, repeatable architecture in this 
study. The pore range is also within the range of the reported trabecular pore sizes, 300 ~ 
1000 µm [59,60].   
Regarding bone ingrowth from µ-CT images, we did not observe any significant 
difference between the scaffolds designs, such as pore size, which is in agreement with 
our previous studies [15,43].  The distances of bone penetration into the PLLA scaffolds 
in this study was more than previously reported in PLGA foams implanted in the rat 
mesentery for 49 days [20].  The distances generally increased from 4 to 8 weeks in our 
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study, while the previous study showed that there was little increase over the implantation 
time.  This may be due to their use of foam scaffolds, which have random oriented pores 
and non-controlled internal architectures, and a more tortuous pathway that may prevent 
nutrient diffusion and cell migration into the scaffolds [24].  Silva et al. demonstrated that 
porous HA and PLLA scaffolds with aligned channels could improve cell infiltration into 
the center of the scaffolds [61].  Their study and our results indicate that orthogonally 
interconnected porous architectures may not only help increase nutrient diffusion when 
compared to foam scaffolds, but may also guide tissue ingrowth.   
Other scaffold design parameters, such as porosity and surface area, did not seem to have 
a significant effect on bone formation in this study.   Although high porosity has been 
discussed as an important requirement of scaffolds [62], the effect of scaffold porosity on 
bone formation was not significant in this study.  Since our scaffolds have fully and 
orthogonally interconnected pore architectures or channels, infiltration of nutrients into 
the scaffolds may not be different between the scaffold design groups.  The pore sizes of 
the scaffolds varied the surface areas of the scaffolds onto which cells from host tissue 
can attach.  The μ-CT data also showed that the patterns of bone ingrowth followed the 
internal architectures of the scaffolds.  Small PLLA scaffolds had the smallest strut sizes 
and pore sizes which allowed the tissues to surround the struts and interlock, increasing 
tissue integration.  This may help to form stronger bonds between the regenerated tissues 
and porous scaffolds.  The scaffolds with smaller pores had more total surface area than 
the scaffolds with larger pores, which may create a larger surface area for cell adhesion 
and help bone formation.  Furthermore, another scaffold design parameter may have a 
more impactful factor on increasing bone formation.  For example, it has been postulated 
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that pore interconnectivity and permeability may be an important scaffold design 
parameters [24,63,64]. 
For functional use of these scaffolds at load bearing sites, it is important to understand 
the time dependent changes in scaffold/tissue construct mechanical properties.  Initially, 
the fabricated PLLA and 50:50PLGA scaffolds had mechanical properties in the low to 
medium range of human trabecular bone [35].  After implantation, the mechanical 
properties decreased due to the degradation of materials.  As shown in the histology and 
μ-CT images, 50:50PLGA scaffolds completely lost their designed architectures, and 
their mechanical properties decreased dramatically both at 4 and 8 weeks compared with 
the pre-implanted scaffolds and the PLLA scaffolds.  Despite the retention of designed 
architecture, PLLA scaffolds also showed a decrease in their mechanical properties, 
which indicates some polymer degradation.   
The mechanical properties of PLLA scaffolds with bone tissue were significantly 
higher than those of 50:50PLGA scaffolds at 4 and 8 weeks.  There was no correlation 
between bone volume and PLLA/bone construct mechanical properties at 4 and 8 weeks.  
However, the 50:50PLGA/bone construct mechanical properties showed some correlation 
with bone volume at 4 weeks, which increased at 8 weeks. The mechanical properties of 
the PLLA scaffold constructs, due to the greater retention of polymer architecture and 
mechanical properties were likely more dependent on the polymer at 4 and 8 weeks.  In 
contrast, the 50:50PLGA mechanical properties were solely dependent on the generated 
bone as the polymer was degraded by 4 weeks.   
Although, the majority of PLLA mechanical properties relied on the scaffold material, 
Large and Medium PLLA scaffolds still exhibited an increasing trend in mechanical 
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properties due to higher mineralized tissues and bone growth on/into the scaffolds from 4 
to 8 weeks.  Small PLLA scaffolds had similar mechanical properties at both time points.  
Small PLLA scaffolds may have a slower degradation speed, maintaining their 
mechanical properties longer than the other groups.  
One of the limitations in this study is that ectopic sites do not provide the same 
environment as orthotopic sites, including mechanical stimulation, nutrients, cell types 
and cell-cell interactions.  For example, the bone volume of PLLA scaffolds decreased 
from 4 to 8 weeks, similar to findings by Lin et al. [42].  This may because there is little 
loading on the ectopic models to simulate bone remodeling and increases in 
mineralization of newly formed tissues [65] as well as less nutrient supply.  In addition, 
mechanical loading on the scaffolds would increase the degradation of PLLA scaffolds in 
terms of molecular weight and mechanical properties [66].   
 
4.6 Conclusions 
     In the present study, we compared the effect of materials and architectures of porous 
scaffolds on bone formation. Our data demonstrated that material choice significantly 
influences in vivo bone tissue regeneration and mechanical properties.  We also found 
that scaffold architecture controls the patterns of bone ingrowth and mechanical 
properties of scaffold-bone constructs.  The 50:50PLGA scaffolds degraded rapidly, 
providing little initial support for bone ingrowth, and had very low mechanical properties.  
In comparison, the PLLA scaffolds maintained their architectures throughout the study 
period and supported some blood vessel and bone ingrowth.  Given the long tissue 
regeneration time seen in many clinical applications (e.g. spine fusion, long bone defects, 
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mandibular defects) the ability of a polymer scaffold to maintain structural and 
mechanical properties up to 6 month is critical.  Pore size, if architecture is maintained 
and does not collapse, does not significantly influence bone regeneration.  The patterns of 
bone tissue ingrowth were defined by the computer designed pores and struts of the 
scaffolds.  Furthermore, mechanical properties of implanted scaffolds can be controlled 
by the initial architectures.  All of these results support the importance of choosing 
suitable scaffold materials and designing conductive scaffold architectures that are ideal 
for bone tissue regeneration.  Each of these factors will need to be fine tuned in order to 
find the desired properties for specific anatomical sites or defects. 
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CHAPTER 5 
Architecture Effects on Long Term In Vivo Degradation in Computer Designed 
Poly (L-lactic acid) 3D Porous Scaffolds 
 
5.1 Abstract 
Current developments of computer aided design and solid freeform fabrication (SFF) 
techniques enable fabrication of scaffolds with precisely designed architectures and 
mechanical properties.  The present study demonstrates the effect of precisely designed 
3D scaffold architectures on in vivo degradation.  Specifically, three types of porous Poly 
(L-lactic acid) (PLLA) scaffolds with variable pore size strut size, porosity, and surface 
area fabricated by SFF, and one PLLA solid cylinder design were implanted into mice 
subcutaneously for 6, 12 and 21 weeks.  The solid cylinders exhibited faster mass loss 
than all porous scaffolds.  Among the porous scaffolds, the group with the largest strut 
size lost mass faster than the other two groups.  Strong correlations between surface area 
and weight loss were found at 12 (R
2
=0.681) and 21 (R
2
=0.671) weeks.  Scaffold 
porosity, however, was not significantly correlated with degradation rate.  Changes of 
molecular weight and crystallinity also showed changing of the chemical structures due 
to degradation, and the solid cylinders had faster crystallization due to advanced 
degradation than the porous scaffolds.  Scaffold mechanical properties decreased with 
degradation, but maintained modulus in the lower range of the human trabecular bone 
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even after 21 weeks.  The loss in mechanical properties, however, was a complex 
function of both degradation and the initial scaffold architecture.  This study suggests that 
computer aided design and fabrication, within a given material, can significantly 
influence scaffold degradation profiles.   
 
5.2 Introduction 
Bone graft substitutes, such as metal, have been historically used to repair bone 
defects.  However, these implants are not ideal since they do not degrade in the body, 
which may lead to chronic problems, such as implant loosening and infection.  
Furthermore, most metal implants are much stiffer than bone, often causing stress 
shielding and bone resorption.  As an alternative approach, tissue engineered scaffolds 
have been developed using biodegradable materials.  The role of tissue engineered 
scaffolds is to fill defects and support new tissue generation during healing process.  
During the process, scaffolds should degrade in concert with newly generating bone, 
providing a smooth transition in load bearing from scaffold to tissue [1].   
The rate of scaffold degradation is affected by various factors including molecular 
weight, ratio of co-polymers, crystallinity, morphology, stress, in vitro or in vivo 
environment, and implantation sites [2-4].  The influence of polymer scaffold architecture 
on degradation has been widely postulated.  For example, poly (lactic-co-glycolic acid) 
(PLGA) films or solid materials degrade faster than the porous PLGA scaffolds, and 
more homogeneous degradation occurs in the scaffolds than the films [5,6].  Lower 
porosity and permeability accelerated PLGA scaffold degradation in vitro [5,7].  Several 
studies have examined the degradation of porous poly (L-lactic acid) (PLLA) scaffolds in 
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vitro [8-13], and showed that thicker walls degrade faster than thinner ones due to the 
autocatalysis of lactic acid, and a higher surface per volume ratio decreases degradation 
rate [11,13].   
Although the previous studies examined the relationship between scaffold 
architectures and degradation behavior, most of the porous scaffolds were sponge shaped 
or nanofibrous scaffolds whose internal architectures, such as pore interconnectivity, 
location, and strut size, could not rigorously be controlled and did not have sufficient 
mechanical properties for bone tissue engineering applications [14-19].  The significant 
architectural variations often lead to conflicting and confusing conclusions.  For example, 
porous scaffolds were found to degrade faster than solid block polymers [20,21], which 
contradicts aforementioned results of faster degradation in solid materials versus porous 
materials [5,6].  In addition there have only been a few studies examining the degradation 
of PLLA scaffolds in vivo [9,22,23].  In vivo studies are obviously critical to simulate the 
clinical application, and furthermore are necessary to understand degradation profiles of 
PLLA scaffolds, since poly ester scaffolds tend to degrade faster in vivo than in vitro [22-
24]. 
To have better controlled scaffold architectures for desired properties, our group and 
others have utilized computer aided design and solid freeform fabrication (SFF) 
techniques [25-28].  SFF techniques allow for the fabrication of porous scaffolds with 
specific architectures and have sufficient mechanical properties for load bearing 
application [16].  In addition, various SFF fabricated scaffolds have been tested in 
animals for bone applications [29-33].  A few studies have also shown the degradation of 
SFF scaffolds in vitro [12,34,35].  However, the effects of specific designed SFF scaffold 
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architectures on in vivo degradation (including mechanical properties) have not been 
rigorously studied.  Since scaffold degradation in concert with bone regeneration is 
critical to attaining eventual clinical success, understanding how scaffold architecture 
affects scaffold degradation is important for improved bone reconstruction outcomes.  
PLLA, is a widely used biomaterial for orthopaedic [36] and spine implants [37], and 
is being researched for tissue engineered scaffolds [9-12,38].  Under physiological 
conditions, PLLA degrades by hydrolysis of ester bonds and forms lactic acid.  Lactic 
acid is further broken down to pyruvate by lactate dehydrogenase, and enters the citric 
acid cycle, where it is converted and removed from the body as carbon dioxide and water 
[4,9,39,40].  It is also well known that PLLA degradation entails molecular weight (Mw) 
loss, mechanical property reduction, and then morphology changes [41].  During 
degradation, other important physical properties also change, including melting point 
(Tm), glass transition temperature (Tg), crystallinity and mass of implants [7,11,12,38].   
The goal of this study was to determine the effect of architecture on in vivo 
degradation of the designed porous PLLA scaffolds.  We specifically hypothesized that 
architectural parameters affecting autocatalysis, namely strut thickness that controls acid 
diffusion and surface area, which controls acid removal from the scaffold, would affect 
degradation rate more significantly than other widely studied architectural variables like 
porosity and pore size.  Three types of scaffolds were designed and fabricated using 
image based design and indirect SFF techniques [42].  In addition, solid cylinders were 
fabricated at the same time.  All of the fabricated scaffolds and cylinders were implanted 
into subcutaneous sites of mice for 6, 12 and 21 weeks.  Mass loss, mechanical property, 
molecular weight, crystallinity, and morphology were analyzed and correlated with 
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specific measurements of scaffolds architecture, including  pore and strut size, porosity, 
and surface area.     
 
5.3 Methods 
5.3.1 Porous Scaffold Design and Fabrication 
Cylindrical porous scaffolds of 5mm diameter and 3mm height with three different 
pore diameters (280, 550, and 820µm), were designed using image-based techniques (Fig 
5.1 (a)).  Based on the designed pore sizes, scaffolds were denoted as PLLA-L (Large 
pore size = 820µm), PLLA-M (Medium pore size = 550µm), or PLLA-S (Small pore size 
= 280µm).  The resulting image representations were converted to stereolithography 
(STL) formats and sliced in Modelworks software (Solidscape, Inc., Merrimack, NH) to 
fabricate wax molds using a ModelMaker II (for PLLA-L and PLLA-M) or 
PatternMaster  (for PLLA-S) 3D printer (Solidscape, Inc., Merrimack, NH).  These wax 
molds were used to cast hydroxyapatite ceramic (HA) secondary molds. PLLA polymer 
pellets (Birmingham Polymers Inc., AL) were heated at 210ºC in a Teflon mold in 
Lindberg/Blue M Vacuum Oven (Thermo Scientific, Asheville, NC), and polymers were 
periodically added until the desired volume was achieved.  The HA molds were then 
placed into the Teflon mold containing molten polymer, in order to force the polymer 
through the open pore network.  The polymer and HA composites were cooled down at 
the room temperature in the oven, and cooling rate in the oven was monitored using a 
Traceable Expanded-Range Thermometer (Fisher Scientific).  The HA molds were then 
removed from the porous polymer scaffolds using RDO Rapid Decalcifier (APEX 
Engineering Products Corp, Plainfield, IL) and rinsed in 100% ethanol.  The PLLA solid 
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cylinders (PLLA-C) were also cast in the Teflon mold at the same time as the porous 
scaffolds.  The cast PLLA-Cs were trimmed on top and bottom using a diamond saw 
(Crystalite Co., Westerville OH), to achieve 3mm height.  Over 8 scaffolds per group 
were cast each time, and 4 casting cycles were performed to obtain enough number of 
scaffolds.  
 
5.3.2 µ-CT analysis of pre- and post- implanted scaffolds  
All of the scaffolds were scanned using a MS-130 high resolution µ-CT Scanner (GE 
Medical Systems, Toronto, CAN) at a resolution of 16 m before and after implantation. 
The scanned images were reconstructed using MicroView software (GE Healthcare, 
Milwaukee, WI) and stored as .vff files.  The reconstructed images were used to calculate 
architectures of the pre-implanted scaffold, regarding pore size, strut size, volume, 
surface area and porosity. 
 
5.3.3 Scaffold implantation 
All animal implants were performed in compliance with University Committee on Use 
and Care of Animal (UCUCA) regulations.  Prior to implantation, the scaffolds and 
cylinders were sterilized in 70% ethanol overnight, and filled with 60µl of 5mg/ml 
bovine plasma-derived fibrinogen (Sigma), and gelled with 6µl of 100U/ml bovine 
plasma-derived thrombin (Sigma).  Immunocompromised mice (N: NIH-bg-nu-xid, 
Charles River, Wilmington, MA) were anesthetized with an injection of 
ketamine/xylazine, and then 4 subcutaneous pockets were created by blunt dissection.  
Each animal received a total of 4 implants (one scaffold or cylinder from each group) by 
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placing one individual implant into each pocket.  Finally, all the surgical sites were 
closed using wound clips.  The mice were sacrificed at 6, 12 and 21 weeks after the 
implantation, and the scaffolds and surrounding tissues were harvested.  
 
5.3.4 Weight analysis of scaffolds 
Tissues surrounding the harvested scaffolds were removed using collagenase solution 
as previously reported [43,44].  Briefly, the samples were treated with type 1 collagenase 
solution (collagenase (Sigma, C-9891): 2000U/ml + buffer (0.05M Tris-HCl and 0.36mM 
CaCl2)) solution at 37ºC for 24 hours followed by 1% v/v of aqueous solution of Triton-
100 washing for 24 hours.  The samples were then rinsed in deionized water for 24 hours.  
Then, the samples were frozen at -20ºC freezer for 12 hours and lyophilized at -80ºC for 
24 hours using a lyophilizer (FreeZone 6, Labconco Corp.) and weighed using an 
analytical balance (Sartorius Extend Balance).  The weight loss was defined as (W0-
Wt)/W0* 100%, where W0 and Wt are the weights of scaffolds before and after 
implantation respectively [3,9]. 
 
5.3.5. Mechanical testing of scaffolds  
Following post-implantation µ-CT scanning, compression tests were performed using 
a MTS Alliance RT30 Electromechanical test frame (MTS Systems Corp., MN) with a 
cross head speed of 1mm/min after scaffolds were immersed in phosphate buffer solution 
for 30 minutes.  The heights and the diameters of the scaffolds were measured with a 
caliper (ABS Digimatic Solar Caliper, Mitutoyo Corp.) and TestWorksk4 software (MTS 
Systems Corp., MN) was used to record load and displacement data.  The stress-strain 
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curves were calculated from the initial dimensions of specimens.  The compressive 
modulus was defined by the slope at the initial linear section of the stress-strain curve.    
 
5.3.6 Differential Scanning Calorimetry 
To determine crystallinity, the enthalpy of the polymers was measured using 
differential scanning calorimetry (DSC).   3 to 5 mg of each sample were weighed using 
an analytical balance and sealed in volatile aluminum sample pans.  The samples were 
heated in a Perkin-Elmer DSC-7 from 25 to 200 ºC at a rate of 10 ºC/min.  An empty pan 
was used as a reference. 
 
5.3.7 Gel Permeation Chromatography (GPC) 
Samples were placed in glass vials and dissolved in HPLC reagent grade chloroform 
(Fisher, C607-4) with 3mg/mL concentration.  The vials were capped to prevent 
evaporation of the chloroform and left for 10-24 hours.  The solution was filtered with 
0.2-PTFE syringe filters.  GPC analysis of the samples was performed in chloroform at 
1mL/min flow rate on a Waters GPC system equipped with a refractive index detector.  
The dissolved samples were eluted through a Waters column (Styragel HR4, 
WAT044225, 7.8mm I.D. x 300mm).  Polymer molecular weights were calculated 
relative to selected polystyrene standers of molecular weights of 400000, 300000, 200000, 
50000, 25000, and 1000 (PolySience Inc., Warrington, PA).  Data was analyzed using 
Millennium software (Waters Corporation). 
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5.3.8 Statistical analysis 
Statistical analysis was performed using SPSS (SPSS, Inc., Chicago, IL USA). N = 5 
or 6 scaffolds were used for weight analysis, and N = 4 or 5 scaffolds were used for 
polymer crystallinity, molecular weight analysis and mechanical tests.  One-way 
ANOVA followed by Tukey’s Post Hoc multiple comparisons test was used.  Errors were 
reported in figures as the standard deviation (SD) and significance was determined using 
probability value of p<0.05.  
 
5.4 Results 
5.4.1 Fabrication and Evaluation of the fabricated scaffolds 
The designed scaffolds shown in Fig 5.1 (a) were fabricated using indirect SFF.  The 
cooling rates of the polymers after heating were also monitored as shown in Fig 5.1 (b) 
and the cooling profiles to ambient temperature were consistent throughout the all casting 
cycles.  The fabricated scaffolds were scanned using µ-CT to assess the morphologies of 
the scaffolds, regarding pore and strut sizes, volume, and surface area (Fig 5.2, Table 5.1).  
It was confirmed that the fabricated porous scaffolds had orthogonally interconnected 
pores or channels, and closely matched the computer design.  The high R-squared values 
reflected the high correlations between the computer design and the fabricated scaffolds 
which were 0.9821, 0.9998, 0.9994 and 0.9890, for pore size, strut size, total volume and 
surface area, respectively (Fig 5.2 (a-c)).  The pore and strut sizes were significantly 
different between the porous scaffold groups, ranging from largest to smallest as PLLA-L 
to PLLA-M to PLLA-S (Fig 5.2 (a)).  The porosities of PLLA-L and PLLA-M were 
similar, and higher than those of PLLA-S and PLLA-C (Fig 5.2 (b)).  Due to some air 
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bubbles from the casting process, PLLA-C did not achieve 0% porosity.  The magnitude 
of scaffold surface area as follows PLLA-S, PLLA-M, PLLA-L and PLLA-C (Fig 5.2 
(c)). 
 
Fig 5.1 Computationally designed scaffolds (PLLA-L, PLLA-M, and PLLA-S) and solid cylinder (PLLA-
C) from left to right (a).  Oven temperature profiles after casting scaffolds (b). 
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Fig 5.2 The relation between the design and the fabricated scaffolds, pore and strut sizes (a) volume (b) and 
surface area (c). These results indicate that architectures of the fabricated scaffolds match to those of the 
design.  Surface (d) area and porosity (e) of the fabricated scaffolds and cylinders were highly reproducible 
within designs. 
 
Table 5.1 Dimension of design and fabricated scaffolds and cylinder 
  PLLA-L PLLA-M PLLA-S PLLA-C 
Pore Size (mm) Design 
Fabricated 
0.82 
0.80 ± 0.02 
0.55 
0.55 ± 0.04 
0.28 
0.31 ± 0.02 
 
Strut Size (mm) Design 
Fabricated 
0.90 
0.91 ± 0.02 
0.61 
0.61 ± 0.04 
0.42 
0.042 ± 0.04 
 
Total Volume 
(mm3) 
Design 
Fabricated 
31.24 
30.55 ± 1.16 
31.72 
31.48 ± 1.57 
35.27 
40.39 ± 2.34 
 
62.57 ± 2.08 
Surface Area 
(mm2) 
Design 
Fabricated 
145.59 
154.76 ± 7.70 
166.63 
171.31 ± 11.26 
208.72 
224.67 ± 6.95 
 
97.29 ± 4.37 
Porosity (%) Fabricated 47.47 ± 1.60 44.70 ± 2.20 29.74 ± 2.03 1.35 ± 0.76 
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5.4.2 Morphology of the implanted scaffolds 
The outer shapes of the scaffolds were still visible on the back of the mice at 21 weeks.  
After removing the fibrous tissues, visual inspection confirmed the existences of the 
original porous architectures for all scaffolds at all time points.  Color changes were also 
observed especially in PLLA-C (Fig 5.3).  Initially, PLLA-C was yellow-like color (Fig 
5.3 (a)) and then, turned into white after degradation in the animal.  µ-CT also confirmed 
the continued existences of the designed 3D internal architectures at 21 weeks and the 
absence of residual tissues in the scaffolds after collagenase treatment (Fig 5.3(e)). 
 
Fig 5.3 Pictures of implanted scaffolds and cylinders at 0 (a), 6 (b), 12 (c), and 21 (d) weeks.  The colors of 
implants turned from yellow to white along to the implantation times.  The rendering images from µ-CT 
show the existing architectures of porous scaffolds at 12 weeks (e).  All images show PLLA-L, PLLA-M, 
PLLA-S, and PLLA-C from left to right. 
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5.4.3 Mass loss of the scaffolds 
We first examined the effects of the collagenase solution used to remove tissues on 
scaffold mass.  Weight differences before and after the collagenase treatment were -0.14 
± 0.56 %, -0.04 ± 0.17 %, -0.16 ± 0.14 %, and -0.32 ± 0.25 % for PLLA-L, PLLA-M, 
PLLA-S and PLLA-C, respectively.   These are within the tolerances of the scale used; 
therefore, we concluded the effect of the collagenase treatment on scaffold degradation 
was negligible.  The percentage of implants’ mass loss at each time point is shown in Fig 
5.4 and Table 5.2.  PLLA-C lost significantly more percentage mass than all other groups 
at 12 and 21 weeks and more than PLLA-S at 6 weeks.  PLLA-S showed significantly 
less percentage of mass loss than PLLA-M and PLLA-L at 21 weeks.  These results 
suggest that larger strut sizes may cause faster degradation than smaller ones.  The 
relationship of scaffold surface area to percent mass loss was also examined (Fig 5.5).  
Although a weak correlation was seen at 6 weeks (R
2
=0.397) (Fig 5.5(a)), the correlation 
became stronger with longer time points, 12 weeks (R
2
=0.681) (Fig 5.5(b)) and 21 weeks 
(R
2
=0.671) (Fig 5.5 (c)).  Among the design parameters, larger surface area was 
correlated with less mass loss.  There was no relation between scaffold porosity and 
percent mass loss. 
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Fig 5.4  Mass loss of the scaffolds and cylinder each time point.  * and ** indicate significant difference.  
With further implantation time, more significant differences were seen between the groups. 
 
Fig 5.5  The relation between the initial surface area of implants and their mass loss at 6 (a), 12 (b) and 21 
(c) weeks.  +, , ×, and indicate PLLA-L, PLLA-M, PLLA-S, and PLLA-C, respectively.  The R-
squared values are 0.397 at 6 weeks (a), 0.681 at 12 weeks (b) and 0.671 at 21 weeks (c). 
 
5.4.4 Crystallinity of the scaffolds 
Scaffold cystallinity was determined by enthalpy measured with DSC (Fig 5.6, Table 5.2).  
Enthalpy increased in all porous scaffolds up to 21 weeks due to degradation of their 
amorphous regions, and there was no significant difference between the porous scaffolds.  
Meanwhile, the enthalpy of PLLA-C increased up to 12 weeks and decreased thereafter.  
The enthalpy value of PLLA-C was significantly higher than PLLA-S (p = 0.048) and 
PLLA-M (p = 0.044) at 6 weeks, and also higher but not reaching significance for PLLA-
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L (p = 0.050).  At 12 weeks, the solid cylinder enthalpy was significantly higher than the 
porous scaffolds with p values of 0.003, 0.001 and 0.001 for PLLA-L, PLLA-M and 
PLLA-S, respectively.  These results indicate that PLLA-C degraded faster than the 
porous scaffolds with its crystal regions degrading after its amorphous regions. 
 
Fig 5.6  Enthalpy change of PLLA-L, PLLA-M, PLLA-S and PLLA-C.    PLLA-L, PLLA-M, and PLLA-S 
increased their enthalpy which indicate increased their crystalinity.  While, PLLA-C increased its enthalpy 
up to 12 weeks and then decreased at 21 weeks. PLLA-C may be exposed advanced degradation. 
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Table 5.2 Mass loss, Crystallinity, Molecular weight, Polydispersity index and Moduli of the implanted 
scaffolds 
  PLLA-L PLLA-M PLLA-S PLLA-C 
0  
week 
Mass Loss (%) 
Enthalpy (J/g) 
Molecular Weight (Da) 
Polydispersity Index (PDI) 
Modulus (MPa) 
-0.14 ± 0.56 
50.45 ± 2.82 
48565 ± 2257 
2.027 ± 0.022 
85.80±37.70 
-0.04 ± 0.17 
52.78 ± 2.25 
47800 ± 2636 
1.999 ± 0.057 
149.84±72.37 
-0.16 ± 0.14 
51.34 ± 2.08 
49784 ± 3298 
1.950 ± 0.077 
209.96±65.90 
-0.32 ± 0.25 
49.70 ± 2.35 
 
 
642.26±161.54 
6 
weeks 
Mass Loss (%) 
Enthalpy (J/g) 
Molecular Weight (Da) 
Polydispersity Index (PDI) 
Modulus (MPa) 
3.02 ± 1.65 
54.24 ± 0.31 
41986 ± 3225 
2.109 ± 0.084 
46.18±13.15 
2.51 ± 1.88 
54.17 ± 1.91 
43557 ± 4279 
2.088 ± 0.026 
134.75±108.20 
0.79 ± 0.82 
54.22 ± 0.26 
44914 ± 2520 
2.030 ± 0.174 
149.84±54.59 
4.09 ± 1.40 
56.89 ± 1.60 
 
 
539.49±126.80 
12 
weeks 
Mass Loss (%) 
Enthalpy (J/g) 
Molecular Weight (Da) 
Polydispersity Index (PDI) 
Modulus (MPa) 
2.79 ± 2.12 
55.27 ± 1.64 
37368 ± 3634 
2.173 ± 0.146 
73.09±30.16 
2.81 ± 0.93 
54.45 ± 1.28 
37626 ± 2852 
2.077 ± 0.046 
77.89±38.98 
1.10 ± 0.65 
54.77 ± 1.48 
37686 ± 3658 
2.160 ± 0.087 
106.88±59.97 
5.48 ± 0.96 
60.49 ± 2.98 
 
 
437.66±83.35 
21 
weeks 
Mass Loss (%) 
Enthalpy (J/g) 
Molecular Weight (Da) 
Polydispersity Index (PDI) 
Modulus (MPa) 
3.22 ± 1.44 
58.17 ± 4.69 
28898 ± 3332 
2.099 ± 0.129 
50.08±40.98 
4.29 ± 1.99 
57.73 ± 1.27 
30346 ± 3127 
2.153 ± 0.027 
56.38±17.16 
1.13 ± 0.53 
56.67 ± 0.79 
29307 ± 1235 
2.127 ± 0.082 
88.83±36.55 
7.96 ± 1.40 
56.83 ± 1.59 
 
 
288.11±106.69 
 
5.4.5 Scaffold molecular weights and polydispersity index 
GPC analysis was performed for the porous scaffolds to measure molecular weight (Mw) 
and polydispersity index (PDI) (Fig 5.7(a, b), Table 5.2).  Mw of the scaffolds decreased 
as the duration of the implantation time increased indicating that polymer chains were 
cleaved due to the result of in vivo degradation (Fig 5.7 (a)).  However, there was no 
significant difference between the scaffold groups.  PDI also did not show any significant 
difference between groups and implantation times (Fig 5.7 (b)).  The distribution of 
molecular weight showed further molecule change in the polymer of each scaffold group.  
The early time point shows more homogeneity in polymer chain length, while the later 
time points show a heterogeneous distribution of the polymer which indicates the 
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polymer chains may be randomly cleaved into pieces (Fig 5.7 (c, d, e)).  These results 
also indicate that more random polymer chain lengths due to degradation. 
 
 
Fig 5.7  The results of molecular weight (Mw) (a) and polydispersity index (PDI) (b) of porous scaffolds 
were measured at each time point (N= 4-5).   Mw decreased with implantation time for all porous scaffolds, 
while PDI was constant for all the porous scaffolds.  There is no significant difference for either Mw or PDI 
between the groups.  Mw distributions of PLLA-L (c), PLLA-M (b) and PLLA-S (e) show bimodal and 
multimodal distributions (arrows) appeared at 12 weeks and 21 weeks.  These results indicate that the all 
scaffolds were developing a wider range of chain length, with an increase in the number of smaller chains.  
 
5.4.6 Mechanical properties of the scaffolds 
The changes of scaffold and cylinder compressive moduli in relation to implantation time 
were also measured (Fig 5.8 (a), Table 5.2).  The mechanical properties were higher for 
implants with less porosity.  Although all of the implants underwent a decrease in 
mechanical properties from 0 week to 21 weeks, all of the porous scaffold moduli were 
equal or greater than 50MPa.  The decreases of the moduli were not monotonic as shown 
in the ratio of moduli at the given time point divided by the 0 week moduli of that group 
(Fig 5.8 (b)).  The cylinder and small strut scaffolds had a more linear, monotonic 
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decrease in elastic modulus than the medium or larger pore scaffolds.  The larger porous 
scaffolds had less numbers of struts in each scaffolds.  Thus, when one strut broke or 
cracked, the construct tended to break easier than the scaffolds with more numbers of 
struts, which created a more random alteration in compressive modulus.   
 
Fig 5.8 Modulus of scaffolds at the implantation time (a) show loss mechanical properties at each time 
point.   Profiles of mechanical properties were unique of each group, which may indicate that mechanical 
properties depend on scaffold architectures as well as degradation ration.  The average ratio of the moduli 
at each time point to 0 week (b) shows that decrease of mechanical properties more linear on PLLA-C, 
PLLA-S, PLLA-M, and PLLA-L in this order.  
 
  
109 
 
5.5 Discussion     
This study demonstrated the specific effect of scaffold architecture created via 
computer aided design and fabricated techniques on in vivo degradation.  Clinically used 
PLLA implants, such as bone screws and plates, have degradation times reported on the 
order of several years [45,46].  The implantation time in this study, up to 21 weeks, was 
much shorter than the previously tested time periods to avoid the implants completely 
losing their mechanical strength or internal architecture, allowing us to relate changes in 
scaffold properties to the initial design.  The importance of PLLA scaffold architectures 
on their degradation has been examined using rods and porous scaffolds [3,11,12,38].  
PLLA, specifically implants greater than 300µm thickness, were shown to undergo 
heterogeneous degradation [20,47,48].  Since the diameter of the current scaffold struts 
are larger than 300µm, all of the implants in this study are assumed to heterogeneously 
degrade.  
To test our hypothesis, it is important to confirm factors in our process which may 
affect polymer degradation.  The oven cooling temperature may affect properties of the 
fabricated scaffolds, including crystallinity and degradation rate [49,50].  The rate of 
cooling or temperature change was consistent thought all 4 casting cycles for all 
scaffolds’ fabrication.  In addition, acid solution in the RDO decalcifier used to remove 
HA molds may potentially degrade PLLA scaffolds.  Since multiple fabrication runs were 
used to make all groups, an equal number of scaffolds per each experimental group were 
selected from each fabrication run to minimize bias due to inter-process variability.   
The measurements of the fabricated scaffolds showed good correlation with the 
computer designs indicating that our fabrication technique can generate scaffolds with 
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desired architectures [16].  The porosity and surface area of the porous scaffolds and the 
solid cylinders were also compared to test the effect of the parameters on scaffold 
degradation profiles.  All the data supported that the pore size, strut size, porosity and 
surface areas were unique for each group to evaluate the effect of scaffold architectures 
on their degradation. 
A challenge for in vivo degradation studies of porous scaffolds is that implanted 
scaffolds become surrounded and infiltrated by tissues, which are often difficult to 
remove [22].  Since this makes some analyses impossible, especially weight 
measurement, we implanted our scaffolds into ectopic sites and used collagenase solution 
upon harvesting, to digest and remove the fibrous surrounding tissues.  µ-CT data 
confirmed in fact that no residual tissue was present within the scaffolds.  The open pore 
channels of our scaffolds might allow easy solution penetration inside of the scaffolds 
compared with scaffold with random pores.  Also, there was no significant effect of the 
collagenase treatment on scaffold weight change.  All of these results indicated that the 
implanted scaffolds and cylinders were properly treated for the following evaluations. 
All of the implanted porous scaffolds and solid cylinders maintained their internal and 
external architectures during the study period.  The existence of the architectures allowed 
testing for weight change and mechanical properties of the implants.  However, polymer 
degradation was indicated by visual examination and the environmental scanning electron 
microscope (data not shown) demonstrating that color of polymers were changed, and 
small cracks were visible especially on PLLA-C at longer time points [3,51,52].   
During the in vivo degradation period, the PLLA scaffolds and solid cylinders lost 
mass as shown in previous studies [3,9,11-13,52].  In particular, solid cylinders showed 
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faster percentage mass loss than the porous scaffolds, indicating that porous scaffolds 
degrade slower on a normalized basis than solid materials [5,6,13].  Among the porous 
scaffold groups, the weight loss depended on the initial designed architecture, confirming 
that degradation is significantly influenced by initial scaffold design.  The solid cylinder 
and the scaffolds with larger strut size showed faster degradation through the longer 
implantation time, which may be explained by autocatalysis causing thicker materials to 
degrade faster than thinner materials [11,53].  In fact, when polymer degrades, lactic acid 
is released decreasing local pH, causing the autocatalysis process [2,11].  This may be 
seen in the solid cylinder and larger struts of the scaffolds due to more acid by-products 
trapped inside of the material.  
On the other hand, the porous scaffolds had a higher surface to volume ratio than the 
solid cylinders, which helped to more efficiently remove acidic by-products due to 
polymer degradation [11].  Since there was no significant difference of surface to volume 
ratio between the scaffold groups, we did not see any significant correlation between 
surface to volume ratio and scaffold degradation.  However, our study suggested that the 
overall scaffold surface area exhibited a significant correlation with scaffold degradation 
as measured by percent mass loss.  This could be explained by the diffusion of soluble 
oligomers from the surface and from inside of the scaffolds.  On the surface of the matrix, 
the oligomer can be removed or the carboxyl group can be neutralized by body fluid and 
cells to reduce acidity, while these effects are not present inside of the matrix, which 
leads to an increase in acidity [54].  Thus, increasing surface area with constant surface to 
volume ratio may still help to reduce acidic buildup and to slow down degradation.   
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The influence of PLLA scaffold porosity on degradation has been widely studied 
[5,13].  Although our scaffolds had lower porosity than many of previously reported 
porous foams or sponges, our scaffolds degraded slower than the porous PLLA scaffolds 
made with a particle leaching method [9].  Furthermore, in our study, PLLA-S had the 
lowest porosity, but degraded slower than PLLA-M and PLLA-L scaffolds with higher 
porosity.  The possible reason for this is that porous scaffolds with random architectures 
and low interconnectivity inhibit fluid flow that removes acid by-products, and the 
remaining by-products increase local acidity inside of the porous scaffolds.  In contrast, it 
is likely that the orthogonally interconnected pores or channels of our designed scaffolds 
in this study easily allowed body fluid infiltration to remove by-products, which may lead 
to slower scaffold degradation.  
It was reported that the crystallinity increases at the early stage of degradation as a 
result of the degradation of the amorphous regions, and then it decreases at later stages 
[3,11,38,51].  All the porous scaffolds showed increased crystallinity over time, 
indicating that the amorphous regions of semi-crystalline PLLA were degraded 
increasing the portion of crystal regions [3,11].  The crystallinity of the solid cylinder 
increased up to 12 weeks and then decreased at 21 weeks indicating that the majority of 
the amorphous regions degraded first and followed by the degradation of the crystalline 
regions.  These results also support that the solid materials degrade faster than the porous 
scaffolds.   
Although there was no significant difference in molecular weight and polydispersity 
index between the scaffold groups, a decrease in molecular weight was observed in all 
scaffold designs and the solid cylinder with respect to implantation time.  The decrease of 
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molecular weight indicates that longer polymer chains were cleaved into shorter chains 
due to degradation.  Furthermore, a bimodal distribution of the GPC results was seen at 
the later time points, which indicates heterogeneous distributions of PLLA polymer chain, 
because of the faster degradation of amorphous region of semi-crystalline structures or 
various polymer degradation rate inside of the scaffold constructs [52,54].   
Design and fabrication of scaffolds which gradually transfer load to newly generating 
bone [1,55], require an understanding of how the choice of material and design affect in 
vivo degradation.  The results showed that the porous scaffold mechanical properties 
began at the lower to middle range of human trabecular bone, and then decreased to 
around the lower end of human trabecular bone range [56-58].  This suggests that these 
porous scaffolds may be applied to load bearing sites depending on the level of anatomic 
specific loads.  Our previous study showed that newly generated bone tissue improves the 
mechanical properties of scaffold/bone constructs.  Therefore, adjusting scaffold 
architecture via strut size and surface area (based on the degradation characteristics of a 
chosen material) may allow fine tuning of scaffold degradation rate to coincide with bone 
regeneration (depending on the chosen osteobiologic) enabling a smoother load transfer 
between scaffold and new bone.   
However, the interaction between degradation and load bearing mediated by scaffold 
architecture is complex.  Solid cylinders showed a linear decrease in mechanical 
properties, in the range of the previously reported in vivo degradation of rods (49% at 
20weeks) or tensile specimens (35% at 20 weeks) [3,51].  Porous scaffolds with designed 
architecture exhibited a more variable decrease of mechanical properties.  The numbers 
of the struts were different between the scaffolds groups, and the scaffolds with less 
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numbers of struts might have easily yielded if one of the struts broke during compression. 
This complicated dependency of reduced mechanical properties based on scaffold 
architecture can be evaluated using a combination of µ-CT and the finite element method 
to predict strength [16].   
This study has some limitations. Since we used a mouse ectopic site, the implants 
were not exposed to mechanical loads during their implantation.  Mechanical loading is 
an important factor that can accelerate degradation of scaffolds [59,60].  The degradation 
profile may differ in orthotopic sites than ectopic sties, due to the presence of osteoclasts 
or other macrophage type cells.  Bone regeneration may also affect mass transport within 
the scaffold, affecting acid transport, which may also influence degradation.  However, 
the ectopic model represented a simpler in vivo model to directly study architecture 
effects on scaffold degradation. 
 
5.6 Conclusion 
Porous scaffolds with computational designed architectures were successfully 
fabricated using indirect SFF.  All implants showed changes of surface morphology, mass, 
molecular weight, and crystallinity, which indicate degradation of the implants.  The 
ratios of scaffolds degradation were determined by their initial designed architectures.  
Porous scaffolds degraded slower than the cylinders, and scaffolds with larger struts 
degraded faster than scaffolds with smaller struts.  In addition, scaffolds with greater 
surface area degraded more slowly.  Larger porosity and pore size did not affect scaffold 
degradation.  Our study suggests that computer design of scaffold architectures is an 
important factor influencing degradation profiles.  Thus, scaffolds may be 
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computationally designed and fabricated to modulate degradation rate, within the 
degradation boundaries determined by the choice of biomaterial. 
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CHAPTER 6 
Effect of Hydroxyapatite-Coated PLLA and PCL Porous Scaffolds on Bone 
Formation In Vivo  
 
6.1 Abstract 
Biodegradable polymer scaffolds fabricated by computer aided design and solid 
freeform fabrication techniques have desired architectures and mechanical properties for 
bone applications.  However, these polymer scaffolds typically have poor 
osteoconductivity and poor bone ingrowth compared with osteoconductive scaffolds, 
such as, hydroxyapatite and calcium phosphate scaffolds.  We combined SFF techniques 
and biomineral coating to fabricate biodegradable scaffolds with designed interconnected 
architectures and improved osteoconductivity.  PLLA and PCL scaffolds with the same 
design were fabricated using SFF and coated with biomineral layers using modified 
simulated body fluid.  µ-CT results showed that both PLLA and PCL scaffolds had the 
identical structures with orthogonally interconnected pores.  XRD, SEM and µ-CT data 
demonstrated mineral layers were on the surface of the PLLA and PCL scaffolds.  The 
scaffolds were seeded with human gingival fibroblasts either trandsuced with bone 
morphogenic protein 7 (BMP-7) or green fluorescent protein (GFP), and implanted into 
mice subcutaneous sites for 3 and 10 weeks.  From µ-CT and histological data at 3 weeks, 
there was no significant bone ingrowth difference between the coated scaffolds and 
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uncoated scaffolds for both PLLA and PCL.  At 10 weeks, however, the coated scaffolds 
had significantly more bone ingrowth than the uncoated scaffolds.  The bone tissues 
inside of the coated scaffolds had bone marrow-like tissue, while the uncoated scaffolds 
had more fibrous-like tissues.  Mechanical properties of the coated PLLA scaffolds 
improved due to the advanced bone ingrowth compared with the uncoated PLLA 
scaffolds.  This study concludes that combination of the SFF technique and biomineral 
coating improve bone ingrowth of PLLA and PCL scaffolds, and advanced bone 
ingrowth improve mechanical properties of PLLA scaffolds. 
 
6.2 Introduction 
Engineered scaffolds have been researched and developed for bone defect applications.  
Ideal scaffolds should be fabricated to fit to defect shapes, and support mechanical loads.  
Furthermore, they should enhance tissue ingrowth and degrade in conjunction with tissue 
healing [1].  To achieve these goals, computer aided design (CAD) and solid freeform 
fabrication (SFF) techniques have been utilized to fabricate biodegradable scaffolds from 
various material and shapes [2-5].  SFF scaffolds have well controlled and interconnected 
pores to enhance cell migration as well as generate higher mechanical properties for load 
bearing applications compared with conventional scaffolds, such as salt leaching [6-10].   
FDA approved biodegradable Poly (α-hydroxy esters), including Poly (L-lactic acid) 
(PLLA) and Poly (ε-caprolactone) (PCL), have been widely used for orthopaedic 
implants, tissue engineering scaffolds and drug delivery [11,12].  PCL and PLLA both 
degrade by hydrolysis, but show different degradation profiles.  Generally, PCL shows a 
more hydrophobic surface and slower degradation than PLLA [13-15].  Both PLLA and 
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PCL have also been used as scaffolds materials using SFF, and been implanted into 
animals to prove their application for bone formation as shown in the chapter 4 and other 
researches[16,17]. 
One of the disadvantages of the above biodegradable scaffolds is their poor 
osteoconductive property to support bone cell functions and tissue ingrowth into the 
scaffolds compared with hydroxyapatite (HA) and tricalcium phosphate (TCP) scaffolds.  
Biomineral coating of substrate surfaces using simulated body fluid (SBF), which 
contains similar ion components to human blood, is a promising technique to improve the 
osteoconductivity of tissue engineered constructs [18-20].  In this technique, biomaterials 
are immersed in SBF, and then carbonate apatite minerals, which are similar to the 
mineral component of bone tissue, precipitate on the negatively charged biomaterial 
surfaces [19,21,22].  .   
Biomineralization has successfully been applied to various biomaterials including 
metals [23-25], polymers [21,26-29], and the composites of polymers and hydroxyapatite 
or calcium phosphate [27,30,31] to enhance bone cell function and bone tissue 
regeneration.  The mineral coated titanium implants enhance bone ingrowth into the 
channels and more direct bone contact on the surface than the uncoated titanium implants 
which had more fibrous tissue formations [24,25,32].  A few coated biodegradable 
substrates, such as PLGA scaffolds and microspheres, have also shown improved bone 
formation in vivo [33,34].  These studies also showed that biomineral coatings inhibited 
fibrous tissue formation and supported direct bone formation [31,32,34].  
Although the previous studies have shown a positive effect of apatite-coatings on bone 
tissue formation, some studies have not agreed with these results.  Mineral coated salt 
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leaching scaffolds tend to have less open pore structures limiting effective coating at the 
center of the scaffolds and have undeveloped bone ingrowth towards the center of the 
scaffolds [35].  Some other studies showed a diminished effect of biomineral coatings on 
bone formation and fibrovascular tissues, with increased numbers of body giant cells in 
vivo using porous poly (ε-caprolactone-co-L-lactide) scaffolds,  SFF PCL scaffolds or 
SFF porous Titanium scaffolds [27,28,36].  All together, these studies indicate that the 
effect of biomineral coatings of biodegradable scaffolds on in vivo bone formations is 
still not well understood.  Furthermore, the effect of mineralization on different base 
materials has not been studied. 
In the present study, we combined SFF scaffolds with biomineral coating using two 
types of biodegradable polymers with different degradability, PLLA and PCL.  We 
hypothesized that biomineral coated SFF scaffolds would have improved bone ingrowth, 
and the biomineral coating would affect PLLA more than PCL scaffolds.  PLLA and PCL 
scaffolds with the same designs were fabricated using the indirect SFF and coated with 
modified SBF technique.  The fabricated scaffolds were seeded with either bone 
morphogenic protein 7 (BMP-7) or green fluorescent protein (GFP) transduced human 
gingival fibroblasts (HGF), and then, subcutaneously implanted into mice for 3 and 10 
weeks.   
 
6.3 Methods 
6.3.1 Porous Scaffold Design and Fabrication  
Porous scaffolds 5mm in diameter and 3mm in height with 550µm pore diameters 
were designed using image-based techniques.  The resulting image representations were 
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converted to stereolithography (STL) formats and sliced in the Modelworks software 
(Solidscape, Inc., Merrimack, NH) to fabricate wax molds using a PatternMaster  3D 
printer (Solidscape, Inc., Merrimack, NH).  These wax molds were cast into 
hydroxyapatite ceramic (HA) secondary molds. Polymer pellets, PLLA (Inherent 
Viscosity = 0.65dL/g, Birmingham Polymers Inc., AL) and PCL (Molecular weight: 
43,000-50,000, Polyscience Inc.), were heated at 205ºC and 120 ºC, respectively, in a 
Teflon mold.  The HA molds were then placed into the Teflon mold containing molten 
polymer, in order to force the polymer through the open pore network.  The HA molds 
were then removed from the porous polymer scaffolds using RDO (APEX Engineering 
Products Corp, Plainfield, IL) and washed with 100% ethanol. 
 
6.3.2 Mineral coating incubation in mSBF 
Biomineral coating of PLLA and PCL scaffolds were performed by Darilis Suarez-
Gonzalez from Prof. William Murphy’s group at the University of Michigan.  PLLA and 
PCL scaffolds were hydrolyzed in a 0.1M NaOH for 60 minutes to expose carboxylate 
anions that serve as nucleation sites.  After hydrolysis samples were rinsed at least 3 
times with deionized H2O.  Each scaffold was incubated at 37 °C in 15 ml of modified 
simulated body fluids (mSBF) for 14 days under continuous rotation. The mSBF solution 
had a similar composition to that of human plasma but with double the concentration of 
calcium and phosphate, and was prepared as previously reported by Dr. Suarez-Gonzalez 
et.al [22].  Specifically, the following reagents were added to ddH2O heated to 37 °C in 
the order shown; 141mM NaCl, 4.0 mM KCl, 0.5 mM MgSO4, 1.0 mM MgCl2, 4.2 mM 
NaHCO3, 20.0 mM Tris, 5.0 mM CaCl2, and 2.0 mM KH2PO4. The solution was then 
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adjusted to a final pH of 6.8. The mSBF solution was renewed daily in order to maintain 
a consistent ionic strength throughout the experiment. 
 
6.3.3 Scaffold surface characterization 
The surfaces of pre-implanted scaffolds were also examined under a scanning electron 
microscope (XL30 ESEM, Philips).  The environmental scanning electron microscopy 
(ESEM) mode was carried out at10kV and in a humid atmosphere of 0.7 Torr.  The 
surfaces of the coated scaffolds were further investigated using electron scanning 
microscope with energy disperse X-ray spectroscopy (EDS), which was done by Darilis 
Suarez-Gonzalez.   
 
6.3.4 Cell preparation and BMP-7 measurement      
Primary human gingival fibroblasts (HGFs) were purchased (ScienCell, CA).  HGFs 
were cultured and expanded on passage 6 near confluence in Dulbecco's Modification of 
Eagles Medium (DMEM) supplemented with 10% fetal bovine serum, and 1% penicillin 
and streptomycin (Gibco).  The HGFs were infected with AdCMV-BMP-7, a 
recombinant adenovirus construct expressing murine BMP-7 gene under a 
cytomegalovirus (CMV) promoter, at a multiplicity of infection (MOI) of 500 PFU/cell 
for 20hours.  0.5 million cells were seeded into each scaffold by suspending them in 40µl 
of 5mg/ml collagen gel.  The gelation procedure was as follows: Rat tail collagen high 
concentration (stock concentration = 9.03mg/mL, BD Bioscience Discovery Labs, San 
Jose, CA) were diluted with cold sterile 0.02N acetic acid to make 5mg/mL.  As soon as 
0.5N sodium hydroxide with 220 mg/mL sodium bicarbonate to initiate gelation is added 
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to Col I gel mixture, gel contents were mixed with cell and evenly re-suspended.  40µL 
of cell and gel mixture was placed each hole of sterilized custom made Teflon mold, and 
the scaffolds were place on top of gel to enforce infiltration.  This was followed by 
incubation at 37°C for 40 min to solidify gels further. The scaffolds seeded with HGFs 
were transferred in ultra-low cluster 24 well plate (Corning Incorporated, NY) with 
DMEM containing 2% FBS were incubated on an orbital shaker.   The media was 
changed for 2 or 3 days and collected every 48 hours at 7, 24, 21 and 28 days.  The 
collected media was stored at -20 °C, and amount of BMP-7 in the media was measured 
using Human BMP-7 Quantikine ELISA kit (R&D Systems) according to manufacturer’s 
instruction.  
 
6.3.5 Scaffold implantation in mice subcutaneous sites 
Passage 6 HGFs were cultured, transduced with AdCMV-BMP-7 or AdCMV-GFP, a 
recombinant adenovirus construct expressing murine GFP gene under a cytomegalovirus 
(CMV) promoter, with 500MOI.  The transduced HGFs were seeded into scaffolds as the 
same way as the previous section, incubated for 24 hours, and subcutaneously implanted 
into 6-7 weeks old (46-53 days old) female immunocompromised mice (NIHS-bg-nu-xid, 
Harlan,).  After animals were anesthetized with an injection of ketamine/xylazine, 4 
subcutaneous pockets were created and 4 scaffolds (one scaffold from each group) were 
implanted into each mouse, and finally surgical sites were closed with wound clips in 
compliance with University Committee on Use and Care of Animal (UCUCA) 
regulations.  The mice were sacrificed at 3 and 10 weeks after the implantation, and the 
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scaffold and tissue constructs were harvested, fixed with Z-fix (Anatech, Battle Creek, 
MI), and left in 70% ethanol for further assay. 
 
6.3.6 Assay of scaffolds, regenerated tissues, and amount of mineral using µ-CT  
All of the scaffolds pre-implantation alone and post-implantation with tissues were 
scanned using a MS-130 high resolution µ-CT Scanner (GE Medical Systems, Toronto, 
CAN) at a resolution of 16 m. The scanned images were reconstructed using 
MicroView software (GE Healthcare).  The reconstructed images were used to calculate 
the scaffold pore size, strut size, volume and surface area prior to implantation and Bone 
volume (BV) and Tissue mineral density (TMD) were calculated for the scaffolds after 
implantation.  For bone ingrowth calculation, region of interest (ROI) was selected with 
size of 5mm diameter and 1.8mm height located within the center of a scaffold.  The 
bone ingrowth was determined by subtracting the amount of mineral in the ROI before 
implantation from the total amount of mineralized tissue after implantation.  To 
determine the amount of mineral deposition the scaffold surfaces, ROI with 5.6mm 
diameter and 3.5mm height was chosen, and then amount of mineral was calculated 
subtracting before implantation from after implantation. 
 
6.3.7 Quantitative Polymerase Chain-reaction (qPCR)  
The harvested scaffold and tissue constructs were homogenized in Trizol (Invitrogen, 
Carlsbad, CA, USA), and RNA extraction was performed using a PureLink RNA Mini kit 
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions.  1µg of 
RNA from each sample was converted to cDNA by means of the SuperScript III First 
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Strand Synthese kit (Cat#11752 Invitrogen, Carlsbad, CA, USA).  The converted cDNA 
was diluted 1:20 and used for 20µL reactions containing CYBER Green PCR mix 
(Cat#4309155 Applied Biosystems).  As an internal control, GAPDH was simultaneously 
quantified.  Primers for osteocalcin (OCN), Runx2 and GAPDH are shown in Table 6.1. 
Table 6.1 Primers used for qPCR 
 Right Left 
Osteocalcine (OCN) CAAGCAGGGTTAAGCTCACA GGTAGTGAACAGACTCCGGC 
Runx2 GCTCACGTCGCTCATCTTG ACACCGTGTCAGCAAAGC 
GAPDH TGAAGCAGGCATCTGAGGG CGAAGGTGGAAGAGTGGGAG 
 
6.3.8 Mechanical test of scaffolds with regenerated tissue 
Following µ-CT scanning, compression tests were performed after scaffolds were 
undergone series of ethanol and rehydrated in Milli-Q water for 30 minutes, using a MTS 
Alliance RT30 Electromechanical test frame (MTS Systems Corp., MN).  The cross head 
speed was 1mm/min after a preload of 0.227kg (0.5 lbs).  The heights of the scaffolds 
were measured with a caliper, and the TestWorks4 software (MTS Systems Corp., MN) 
was used to record load and displacement data.  The stress-strain curves were calculated 
from the initial dimensions of specimens.  The compressive modulus was defined by the 
slope at the initial linear section of the stress-strain curve.    
 
6.3.9 Histological analysis 
After scanning with the µ-CT machine, one harvested scaffold from each group was 
also used for histological assay.  The scaffold and tissue constructs were demineralized 
with RDO and the residual polymer in the tissue was removed using chloroform prior to 
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paraffin-embedding.  The scaffolds were then sectioned at 5 µm and stained with 
hematoxylin and eosin (H&E) and Masson’s Trichrome. 
 
6.3.10 Statistical analysis 
The statistical analysis was performed with SPSS (SPSS, Inc., Chicago, IL USA).  
Two groups were analyzed with Student’s t-test for independent samples. Multiple 
comparison procedures were determined by one-way ANOVA followed by Tukey’s Post 
Hoc multiple comparisons.  Errors are reported in figures as the standard deviation (SD) 
and significance was determined using probability value of p < 0.05.  
 
6.4 Results 
6.4.1 Morphology of coated and non-coated scaffolds 
The gross images of the fabricated scaffolds are shown in Fig 6.1 (a-d). The scaffolds 
have similar morphology, and become less transparent after mineral coatings.  
Architectures, including pore interconnection, of the non-coated PLLA and PCL 
scaffolds were analyzed using µ-CT (Fig 6.1 (f) and (h)).  Pore size, strut size, volume, 
surface area and surface to volume ratio of non-coated PLLA and PCL scaffolds were 
measured (Table 6.2).  These values were same between the PLLA and PCL scaffolds, 
which support that the scaffolds had identical architectures.  µ-CT data also showed the 
existence of mineral layers inside of the scaffolds architectures (Fig 6.1 (e) and (g)).  The 
surfaces of the scaffolds were further characterized using ESEM (Fig 6.1 (i-p)).  Non-
coated PLLA and PCL scaffolds had smooth surface (Fig 6.1 (j, l, n, p)), while mineral 
coated scaffolds show rough surface (Fig 6.1 (i, k, m, o)).  The surface of the mineral 
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were also characterized, and nanoscale plate-like crystalline structures were observed on 
both coated PLLA and PCL scaffolds (Fig 6.2 (a, b)).  Analysis of the composition of the 
biomineral by energy dispersive x-ray spectroscopy (EDS) showed that the mineral was 
composed primarily of calcium and phosphorous with a Ca/P ratio of 1.58 for coated 
PLLA scaffold (Fig 6.2 (c)) and 1.56 for coated PCL scaffold (Fig 6.2 (d)) which are in 
the rage of biological minerals.  These data support growth of bone-like minerals on the 
surface of the scaffolds. 
 
Fig 6.1 Pictures, µ-CT images, and ESEM images of Coated PLLA (a, e, i, m), Uncoated PLLA (b, f, j, n), 
Coaed PCL (c, g, k, o) and Uncoated PCL (d, h, l, p), respectively. µ-CT images confirm that mineral layer 
covered the surface of both PLLA and PCL scaffolds (e,g). ESEM images show that rough surface of the 
coated PLLA and PCL scaffolds (m, o), while relatively smooth surface of the uncoated PLLA and PCL 
scaffolds (n,p). 
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Table 6.2 Fabricated uncated PLLA and PCL scaffolds 
 Pore Size 
(mm) 
Strut Size 
(mm) 
Volume 
(mm3) 
Surface (mm2) Surface/Volume 
PLLA Scaffold 0.60 ± 0.03 0.67 ± 0.03 33.259 ± 2.194 187.126 ± 13.753 5.627 ± 0.204 
PCL Scaffold 0.61 ± 0.04 0.67 ± 0.03 30.972 ± 1.290 182.220 ± 10.819 5.880 ± 0.131 
 
 
Fig 6.2 SEM images and EDS data of coated minerals of PLLA (a, c) and PCL (b, d) scaffolds. SEM 
images show that nucleated bone like mineral structures on the coated PLLA and PCL scaffolds (a, b).  
EDS data confirmed that existence of calcium and phosphorous peaks (c, d) 
 
6.4.2 Crystallinity  
Crystallinity data of the coated and uncoated scaffolds was shown in Fig 6.3.  The 
uncoated PLLA scaffold showed many peaks due to its semi-crystalline structures (Fig 
6.3 (b)), while the coated PLLA scaffold shows their peak at 2θ = 25.9 and 31.95 (Fig 6.3 
(a)).  The peak at 2θ = 31.95 is wider than that of 2θ = 25.9 due to the combination of 
crystal peaks of mineral and polymer.  In contrast to non-coated PLLA scaffold, non-
coated PCL scaffolds did not show crystal peaks of polymer (Fig 6.3 (d)).  The coated 
PCL also show their crystal peaks at 2θ = 25.9 and 31.95 (Fig 6.3 (c)). 
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Fig 6.3 XRD data of Coated PLLA (a), Uncoated PLLA (b), Coated PCL (c) and Uncoated PCL (d)., and 
the coated PLLA scaffold shows their peak at 2θ = 25.9 and 31.95 (a), and the uncoated PLLA scaffold 
shows many peaks due to its semi-crystalline structures (b).  The coated PCL also show their crystal peaks 
at 2θ = 25.9 and 31.95 (c). 
 
6.4.3 BMP-7 expression in vitro 
BMP-7 secretion from the transduced HGFs was measured in vitro for up to 28days 
(Fig 6.4). All of the scaffold groups showed expression of BMP-7 up to 4 weeks, and the 
amount of secretion decreased for longer time points. There is no significant difference 
between groups.  The coated PLLA scaffolds had less amount and greater standard 
deviation.   
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Fig 6.4 BMP-7 secretion from the scaffolds seeded with BMP-7 transduced HGFs using ELISA. 
 
6.4.4 Bone formation 
The scaffolds with BMP-7 virus transduced HGFs showed bone formation and were 
covered by bone tissues after 3 and 10 weeks implantations from µ-CT images (Fig 6.6), 
while scaffolds with GFP transduced HGFs did not have a boney shell.  The results of 
qPCR show that osteogenic gene expression from all of scaffold groups with transduced 
HGFs (Fig 6.5).  There is a small amount of bone ingrowth into the scaffold constructs at 
3 weeks, and there is no significant difference between the groups (Fig 6.6 (a-d)).  At 10 
weeks, the coated scaffolds showed more bone ingrowth than the non-coated scaffolds, 
and the bone formation followed the architectures of the scaffolds (Fig 6.6 (e-h)).   
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Fig 6.5  Runx 2 (a) and OCN (b) expression at 10 weeks. 
 
 
Fig 6.6 Bone ingrowth into Coated PLLA (a,e), Uncoated PLLA (b, f), Coated PCL (e, g) and Uncoated 
PCL (d, h) at 3 and 10 weeks implantation.  There was a little bone ingrwoth in the all scaffolds at 3 weeks 
(e-h).  Advanced bone ingrowth followed the designed architectures of the coated PLLA and PCL scaffolds 
at 10 weeks (e, h).  
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Bone ingrowth was calculated as the amount of bone in the ROI (Fig 6.7 (a)), and 
tissue mineral density of ROI was also calculated (Fig 6.7 (b)).  There was no significant 
difference between the groups at 3 weeks.  At 10 weeks, the coated PLLA and PCL 
scaffolds had significantly greater bone ingrowth than uncoated PLLA, and PCL 
scaffolds.   In addition, bone ingrowth of the coated PLLA scaffolds was significantly 
higher than that of non-coated PCL scaffolds.  All of the scaffolds increased their tissue 
mineral density from 3 to 10 weeks.  Tissue mineral density of the coated PLLA was 
significantly higher than that of the non-coated PLLA scaffolds which indicates that 
mineral coatings may also help to increase mineralization of tissues on PLLA scaffolds. 
 
Fig 6.7 Calculated bone ingrowth (a) and tissue mineral density (b) in the ROI.  There is no significant 
difference between the scaffolds at 3 weeks.  And, the coated PLLA and PCL scaffolds showed 
significantly more bone ingrowth than the uncoated PLLA and PCL scaffolds at 10 weeks. 
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6.4.5 Deposition of biomineral coating 
Layers of mineral coatings were observed through the study period on control 
scaffolds seeded with GFP transduced HGFs (Fig 6.8 (a-d)), and slightly higher intensity 
of coatings were observed at 10 weeks compared to 3 weeks.  The amount of deposited 
mineral layers calculated from µ-CT also show that more deposition at 10 weeks than 
3weeks period (Fig 6.8 (e)).  All of these data indicates that the more mineral deposition 
occurred in our study instead of mineral dissolution. 
 
Fig 6.8 Scaffolds seeded with GFP transduced HGFs had no bone shell.  The existence of mineral layers on 
the surface of the coated PLLA and PCL scaffolds were observed at 3 (a, b) and 10 (c, d) weeks.  
Deposition of mineral was calculated by CT, and there are increases of mineral from 3 to 10 weeks (e). 
  
137 
 
6.4.6 Histology data 
Harvested scaffolds with BMP-7 transduced HGFs were evaluated using histological 
techniques, H&E (Fig 6.9 and Fig 6.10 (a-d)) and Masson’s Trichrome (Fig 6.9 and Fig 
6.10 (e-h)).  H&E staining shows that there was little bone formation in the pores of the 
coated and uncoated PLLA and PCL scaffolds at 3weeks (Fig 6.9 and Fig 6.10 (a, b)).  
However, the pores of the coated scaffolds contained blood vessel like tissues, which 
may be precursor of bone ingrowth (Fig 6.9 and Fig 6.10 (a)).  In contrast, the uncoated 
scaffolds showed few blood vessels (Fig 6.9 and Fig 6.10 (b)).  Then, well developed 
bone tissue ingrowths was observed in the pores of the coated PLLA and PCL scaffolds 
at 10 weeks (Fig 6.9 and Fig 6.10 (c)).   The bone tissue followed the pore architectures 
of the scaffolds containing bone marrow like tissues.  The uncoated PLLA and PCL did 
not have much bone ingrowth at 10 weeks point and contains fat-like tissues in the pores 
(Fig 6.9 and Fig 6.10 (d)).  Masson’s trichrome staining also showed little bone tissue in 
the pores of coated and uncoated PLLA and PCL scaffolds at 3 weeks (Fig 6.9 and Fig 
6.10 (e, f)).  At 10 weeks, however, the coated PLLA and PCL scaffolds had well 
developed bone tissue containing osteoid, unmineralized matrix (Fig 6.9 and Fig 6.10 (g)), 
indicating active deposition of bone minerals in comparison to the uncoated scaffolds.  
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Fig 6.9 Histological evaluation of implanted PLLA scaffolds.  H&E staining shows that little bone 
ingrowth in both the coated and uncoated PLLA scaffolds (a, b).  At 10 weeks, there are well developed 
bone ingrowth containing marrow like tissues in the coated PLLA scaffolds (c), and more fibrous like 
tissues in the uncoated PLLA scaffolds (d).  Masson’s Trichrome staining also shows similar results to the 
H&E staining, and further show the osteoid deposition in the coated PLLA scaffolds at 10 weeks. 
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Fig 6.10 Histological evaluation of implanted PCL scaffolds.  H&E staining shows that little bone ingrowth 
in both the coated and uncoated PCL scaffolds, however, more blood vessel like tissues in the coated PCL 
scaffolds at 3 weeks (a, b).  At 10 weeks, there are well developed bone ingrowth containing marrow like 
tissues in the coated PCL scaffolds (c), and more fibrous like tissues in the uncoated PCL scaffolds (d).  
Masson’s Trichrome staining also shows similar results to the H&E staining, and further show the osteoid 
deposition in the coated PCL scaffolds at 10 weeks.  
 
6.4.7 Mechanical testing of scaffolds with and without bone tissue 
Elastic modulli of scaffolds with BMP-7 transduced HGFs were determined at both 
time points (Fig 6.11 (a)).  Elastic moduli of both coated and uncoated PLLA scaffolds 
decreased after scaffold implantations from 0 to 3 weeks due to polymer degradation 
(p=0.046 and 0.001, respectively).  The moduli of the coated PLLA scaffolds 
significantly increased from 3 to 10 weeks (p = 0.046), however, the increase of uncoated 
PLLA scaffolds was not significant (p = 0.590).  Uncoated PCL scaffolds also 
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significantly increased their mechanical properties from 3 to 10 weeks (p = 0.028).  
Although the coated PCL scaffolds did not have significant improvement of their 
mechanical properties, the p value was close to the significant level (p = 0.073).    
Elastic moduli of the scaffolds with GFP transduced HGFs were also tested (Fig 6.11 
(b)).  Only uncoated PLLA scaffold showed significant decrease of moduli from 0 to 3 
weeks.  Moduli of coated and uncoated PLLA scaffold also increased from 3 to 10 weeks, 
but not significantly, maybe, due to more fibrous tissue formation due to polymer 
degradation.  The coated and uncoated PCL scaffolds show constant moduli throughout 
the study period. 
 
  
141 
 
 
Fig 6.11 Elastic moduli of the scaffolds with generated bone tissues (a) and non-bone tissues (b). The 
coated and uncoated PLLA scaffolds lost their mechanical properties from 0 to 3 weeks due to the 
degradation of polymers. And the mechanical properties of the coated PLLA scaffolds increased 
significantly from 3 to 10 weeks, while the uncoated PLLA did not have significant increase (a).  Both 
coated and uncoated PCL scaffolds showed significant or close to significant increase of mechanical 
properties (a).    
 
6.5 Discussions 
Computer aided tissue engineering has been developed to fabricate scaffolds with 
precisely controlled architectures to match anatomical shapes and achieve desired 
properties for clinical applications.  Many SFF techniques enable fabrication of designed 
scaffolds using biodegradable materials, including PLLA, PLGA and PCL.  However, 
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their hydrophobicity and poor osteoconductivity needed to be overcome to enhance bone 
ingrowth.  In addition, although some research showed biomineral coatings on PLLA and 
PCL scaffolds [37,38], no study has performed coating SFF PLLA and PCL scaffolds 
with the same architecture.  To achieve fully developed bone ingrowth in porous 
scaffolds, we developed the combination of SFF scaffolds and mSBF techniques using 
two different polymers, PLLA and PCL, fabricated using identical process.     
To test our hypothesis, PLLA and PCL scaffolds need to have the identical structures 
and the mineral coating should cover the entire scaffold surfaces.  µ-CT data 
demonstrated that the fabricated PLLA and PCL scaffolds had the identical structure and 
orthogonally interconnected pores or channels, which agreed with our previous SFF 
scaffold studies including PLLA, 50:50PLGA, and PCL scaffolds [7,39].  The µ-CT was 
also used to confirm that entire surface of the porous scaffolds were successfully coated 
with mineral layers [40].  These fully designed interconnected channels also allowed 
infiltrating mSBF solution into the center of the scaffolds to allow biomineral layers to 
cover the center of scaffolds.  This is an advantage of SFF scaffolds compared to salt 
leaching scaffold which tend to have less open pore structures terminating effectively 
coat at the center of the scaffolds [35]. 
mSBF has been studied to grow mineral layers on biodegradable materials [33,41,42], 
and SFF scaffolds [43].  The coated mineral layers have plate-like morphology which is 
similar to human bone tissues.  EDS data shows calcium and phosphate peaks on the 
coated mineral which indicated both coated PLLA and PCL scaffolds had nucleated 
mineral, similar Ca/P ratios to each other which is near that of hydroxyapatite [21,41].   
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Both coated scaffolds showed crystal peaks of mineral at 26 º and 32º which 
correspond to the (002) plane and (211) (112) planes of apatite [44]. Coated PLLA 
showed a wider peak at 32º where crystal peaks of PLLA also exists, and many peaks 
besides crystal peaks due to crystal structure of PLLA polymer, which was confirmed 
from the XRD data of uncoated PLLA scaffolds [45].  In contrast, coated PCL showed 
two peaks from the PCL polymer around 21º and 24º, similar to a previous study [46].  
To generate bone tissue in an ectopic site, ex vivo gene therapy with adenovirus BMP-
7 was used.  In vitro BMP-7 secretion results showed that secretion decreased at longer 
time points, which is different than the consistent secretion of BMP-2 from adenovirus 
transduced HGFs up to 2 weeks in vitro [47].  As similar to our previous scaffolds studies, 
bone shells formed surrounding the scaffolds [39,48,49].  qPCR data show signals of 
early osteoblast differentiation with Runx2 and late tissue mineralization with OCN, 
which support the fact that the bone shells contain osteogenic factors [50,51].  In contrast, 
the control groups with GFP transduced HGFs showed very little bone gene expression 
and did not generate bone shells. The groups with BMP-7 transdueced HGFs only 
contributed the bone formation.    
In the µ-CT images, generated bone tissues have similar density to initially coated 
mineral layers, and it is difficult to separate generated bone tissues from original mineral 
coating.  Since most of mineral layers have lower threshold value than 1100, we chose 
the threshold value (1100) to determine bone tissues in the scaffolds.   
From the µ-CT data, no significant difference in bone ingrowth in the coated scaffolds 
was observed at 3 weeks compared to the uncoated scaffolds.  The mineral coated 
scaffolds showed significantly greater bone ingrowth at 10 weeks which agrees with 
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some previous studies.  Mineralized porous PLGA scaffolds showed higher bone 
formation than the non-mineralized scaffolds in rat cranium critical defects [33].  
Improvements of bone formation were also found using mineralized PLGA microspheres 
implanted into mice subcutaneous sites [34].  A significant advantage of combining SFF 
with biomineralization is the completely connected growth bone, something difficult with 
salt leached scaffolds [35].  Thus, SFF scaffolds have designed fully connected channels 
which would allow to body fluid infiltration into the center of the scaffolds to support 
tissue ingrowth [6,8-10].  
In ex vivo gene therapy, large bony shells tend to form outside of the scaffolds, and the 
layers of tissues may prevent diffusion of nutrients into the center of the scaffolds [52].  
This may also cause accumulation of acidic by-product inside of the implants, which 
could prohibit cell migration and tissue ingrowth.  However, histological images shows 
the coated scaffolds had more blood vessel-like tissue containing bone marrow compared 
with the uncoated scaffolds at 3 weeks.  This may enhance bone cells in the marrow like 
space to lead advanced bone ingrowth at 10 weeks since invasion of blood vessel helps 
tissue ingrowth.   
The mechanisms of mineral coating on advanced bone formation have not been fully 
understood.  Biomineral coating increase hydrophilicity PLLA and PCL scaffolds, which 
may help cell adhesion, migration and proliferation [53-55].  Calcium phosphate mineral 
has been reported their capability of protein adsorption for cell adhesion and other bone 
specific proteins [56,57].  The proteins, especially fibronectin and vitronectin, are critical 
for osteoblasts to attach on biomaterials and produce extracellular matrices.   In addition, 
BMP-7 proteins secreted from the HGFs may be attached on mineral coating to help 
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progression of osteogenesis.  Existence of calcium ion from soluble calcium phosphate 
coating is reported to induce cell proliferation and differentiation [58].  
Our result also differs from some of the previous studies using biodegradable scaffolds.  
For example, SFF PCL scaffolds implanted in subcutaneous sites did not show significant 
bone formation on biomineral coated scaffolds [27]. Another study showed that improved 
bone contact on starch-based biodegradable scaffolds at 3weeks but not 6 weeks [59].  
These controversial results may be due to quality of biomineral layers, such as 
crystalinity of minerals [60]. 
Dissolution or absorption of biomineral layers has been discussed effect of cells, such 
as osteoclasts and macrophages, or effect of media in vitro or in vivo [61,62].  The 
scaffolds seeded with GFP transduced HGFs did not generate any bone shells and 
showed the presence of the biomineral layers of the scaffolds over the study period.  This 
agrees with the fact that apatite layers were observed in the soft tissue after 30 weeks [32].  
The µ-CT data in GFP seeded scaffolds demonstrated an increasing mineral layer 
accumulation on the scaffold, similar to previously seen carbonate apatite absorption in 
rat ectopic sites [62].  In contrast, mineral coating in orthotopic sites decreased their 
thickness although it existed at 24 weeks [24].  This can be explained by absence of 
osteoclasts in the ectopic sites which contribute resorption of mineral layers [24,32]. 
Although both PLLA and PCL scaffolds were treated with NaOH in the same manner 
to functionalize their surfaces for biomineral coating, only PLLA scaffold had 
significantly reduced mechanical properties.  This indicates that only PLLA degrades due 
to NaOH treatment which has been used to test hydrolytic degradation of PLLA in vitro 
[63].  Implanted PLLA scaffolds also lost their mechanical properties from 0 to 3 weeks 
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due to degradation of polymer which is similar to our previous studies.  Comparing 
mechanical properties of PLLA with and without bone tissues, PLLA scaffolds with bone 
tissue show lower mechanical properties which indicate that formed bone tissues 
inhibited acid by-products from PLLA and accelerated degradation.  
Mechanical properties of implanted scaffolds in this study tend to increase as longer 
implantation time due to increase of tissue mineral densities.  Advanced bone ingrowth 
increased mechanical properties of the coated PLLA compared with the uncoated PLLA.  
This results agree with the previous studies showing biomineral coated titanium implants 
showed less fibrous tissue and more bone contact on the surface, and had greater 
mechanical properties than uncoated implants [32,64].  In contrast, there is not much 
difference between the p values of the coated and uncoated PCL scaffolds.  This data 
indicates that the coated and uncoated PLLA scaffolds lost their mechanical properties in 
the animal due to their degradation, and then advanced bone ingrowth support the 
mechanical properties of the coated PLLA scaffolds.  PCL scaffolds with slower 
degradation may maintain their mechanical properties over this study time period, and the 
mechanical properties of bone tissues in the scaffolds may not sufficient to influence PCL 
scaffolds moduli.   
The combination of SFF scaffolds and biomineral coating using mSBF presents 
further advantages for porous scaffolds for clinical applications.  Although ceramic 
scaffolds, such as tricalcium phosphate or HA have been used as bone scaffolds due to 
their good osteoconductivity, their brittle mechanical properties as well as their resorption 
rates are still problems.  For example, tricalcium phosphate with Ca:P ratio of 1.5 
dissolves too fast, while hydroxyapatite with a Ca:P raito of 1.67 does not dissolve [65].  
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Some studies suggested that fabrication of polymer and TCP composite scaffolds using 
SFF techniques improved bone formation in vivo [48,66,67].  Compared with the 
previous techniques, the combination of SFF scaffolds and biomineral coating has 
significant advantages.  This approach would improve and control scaffold properties 
since SFF scaffolds have proven control of mechanical properties and degradation based 
on their architectures and biomineral coatings have proven osteoconductivity.  
Furthermore, these techniques allow incorporation and controlled release of multiple 
proteins or DNAs to improve further bone formation [68,69].   
Although we have shown the importance of biomineral coatings on bone formation, 
the bone tissue were generated in ectopic sites without any loadings.  Examining 
biomineral coated scaffolds in orthotopic sites is necessary.  Another advantage of 
mineral coatings is that degradation ratio of the coated scaffolds may be different than 
that of uncoated scaffolds.  The degradation of PLLA creates acidic environments which 
causes autocatalysis of PLLA and accelerate its degradation.  However, ionic calcium 
creates an alkali condition which may buffer the acidic environment and slow the 
degradation speed [34].   
 
6.6 Conclusions 
This study examined the combination of computer aided engineered scaffolds and 
biomineral coatings.  SFF scaffolds made of PLLA and PCL were successfully coated 
with biomineral layers using the same mSBF procedures.  The biomineral coated scaffold 
showed improved in vivo bone formation, and the bone tissues were fully connected and 
follow the scaffold architectures.  PLLA scaffolds demonstrated increased mechanical 
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properties due to the increased bone ingrowth compensating for the loss of mechanical 
properties due to polymer degradation.  Mineral coatings on the scaffolds were present in 
vivo over this study.  In future research, dissolution and precipitation of mineral coating 
on bone formation needs to be further examined.  In addition, biomineral coatings need to 
be fine-tuned depending on scaffold materials to improve further bone formation as well 
as control scaffold degradation.  
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CHAPTER 7 
Summary and Future Work 
 
7.1 Summary 
Engineered porous scaffolds for bone application have been studied over a few 
decades, and many researchers have been examining and discussing ideal scaffolds to 
support bone generation.  The overall goal of this thesis was to fabricate scaffolds with 
the capability of supporting mechanical loads in bone defects, bone formation, and the 
gradual transfer of load bearing from the scaffold to the forming bone tissues as proposed 
by Hutmacher et al. (Fig 7.1 (a)) [1].  We have utilized computer aided design, solid 
freeform fabrication (SFF), and biomineral coating to develop porous scaffolds with 
targeted characteristics, including controlled architectures, mechanical properties and 
surface properties.  PLLA and PLGA, which are FDA approved and currently used as 
orthopaedic and spine products, were mainly used to fabricate scaffolds.  In the last part 
of the thesis, PCL was also used because of its slower degradation compared with PLLA 
and PLGA. 
In chapter three, porous scaffolds with designed architectures and mechanical 
properties were fabricated for load bearing application, essentially having linear elastic 
moduli within the low to middle range of human trabecular bone.  Although there are a 
large number of studies characterizing the mechanical properties of PLGA scaffolds, 
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these scaffolds typically had mechanical properties much less than trabecular bone.  The 
combination of µ-CT and the voxel based finite element method were further used to 
analyze the fabricated scaffolds and showed successful prediction of scaffolds 
mechanical properties, both compressive moduli and yield strength.  Chapter three 
demonstrated the capability of designing and fabricating scaffolds with desired 
architecture and mechanical properties (both linear elastic moduli and yield strength) 
within the range of human trabecular bone.  It was also shown that non-destructive 
techniques combining micro-CT scanning with voxel finite element method could 
accurately predict scaffold mechanical properties, thus providing a method for not only 
design of new scaffolds, but also quality control of fabricated scaffolds. 
In chapter four, the effects of scaffold architectures and materials on bone formation 
were examined using mice ectopic models and ex vivo gene therapy.  50:50PLGA and 
PLLA scaffolds with identical porous architectures were fabricated and implanted for 4 
and 8 weeks.  The 50:50PLGA scaffolds mostly lost their architecture and mechanical 
properties at 4 weeks due to their short degradation time.  In contrast, the PLLA scaffolds 
maintained their architectures over the study period, while losing their mechanical 
properties.  The mechanical properties of scaffold and tissue complex were either 
maintained or improved over scaffold degradation due to some bone ingrowth and higher 
mineralization.  This study concluded that material (in this case, mainly due to 
degradation speed and loss of architecture) had a significant influence while pore size had 
no effect on bone formation.  It was demonstrated that some mechanical properties 
transfer from PLLA scaffolds to composites of scaffold and newly generated tissues, 
while 50:50PLGA completely lost their architectural structure at an early time point (Fig 
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7.1(b)).  This study indicates that PLLA is a more favorable scaffold material for load 
bearing application than 50:50PLGA.   
In chapter five, effects of PLLA scaffold initial architectures on degradation profiles 
were investigated using an ectopic model up to 21 weeks.  The results successfully 
demonstrated that scaffold architecture had a significant effect on degradation (Fig 7.1 
(c)).  Specifically, a scaffold surface areas and strut size, but not pore size and porosity, 
were critical for scaffold design to control degradation.  It was hypothesized that fully 
interconnected porous architectures help to easily remove by-products from the center of 
the scaffolds and avoid acidic concentration, which leads to autocatalysis.  The 
mechanical properties changed depending on the scaffold architectures, specifically, there 
is a complex interaction between material, strut size (large struts perhaps undergoing 
faster degradation but still able to carry load due to larger area), and surface area.  The 
major finding in this chapter is the significant influence of scaffold design, particularly 
strut size and surface area, on scaffolds degradation.   
Through chapters three to five, designed SFF scaffolds showed mechanical properties 
within the range of trabecular bone, and the controlled architecture provided insight into 
how pore size, strut size, porosity and surface area affected bone formation and scaffolds 
degradation.  In chapter six, we combined SFF scaffolds with biomineral coatings to 
achieve further bone ingrowth into scaffolds.  SFF PLLA and PCL scaffolds with the 
same architecture were fabricated and coated with biomineral layer using modified SBF.  
The orthogonally interconnected pore architectures of the SFF scaffolds facilitated 
successful coating of the scaffold internal with biomineral layers.  In vivo results showed 
that both biomineral coated PLLA and PCL scaffolds had fully connected ingrowth (Fig 
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7.2 (b)), while non-coated PLLA and PCL scaffolds had a little bone ingrowth (Fig 7.2 
(a)).  This result demonstrated that biomineral coating successfully improved bone 
formation on biodegradable scaffolds.  Furthermore, fully interconnected pore channels 
of SFF scaffolds allowed tissue ingrowth into the center of the scaffolds.  The advanced 
bone ingrowth also compensated for mechanical properties loss of the coated PLLA 
scaffolds due to degradation.  This study indicated that improved bone ingrowth 
transferred some mechanical load from the scaffold to newly generated tissues (Fig 7.1 
(d)).   
 
Fig 7.1 The relation between scaffolds (Red) and tissue regeneration (Blue).  (a): Ideal scaffolds should 
degrade in concert with new bone regeneration.  (b): Chapter three showed the relation between scaffold 
degradations and bone generation.  50:50PLGA scaffolds degrade in short time; in contrast, PLLA 
scaffolds degraded longer time.  Small bone in growth was observed, but not fully connected.  (c): Chapter 
four revealed the scaffold architectures can control their degradation.  Scaffolds with smaller strut size and 
larger surface area help to slow their degradation.  (d): Chapter six proved that SFF scaffolds with 
biomineral coating improve bone ingrowth, and the advanced bone ingrowth improved mechanical 
properties. 
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Fig 7.2 The schematic images of the relation biodegradable SFF scaffolds and bone ingrowth.  The color 
change of scaffolds indicates degradation of scaffolds after implantation.  (a): Uncoated PLLA and PCL 
scaffolds only have bone tissue formation outside of the scaffolds.  (b):  Biomineral coated PLLA and PLC 
scaffolds successfully had bone ingrowth and filled with trabecular like tissues. 
 
7.2 Future Direction 
This thesis demonstrated that SFF polymer and polymer/CaP coated scaffolds are a 
promising alternative to current metal and calcium implants for bone reconstruction as 
well as the conventional engineered scaffolds.  As for future directions, SFF scaffolds 
with and without coating need to be tested in larger and more clinically relevant 
orthotopic defects instead of small size scaffolds implanted in mice subcutaneous sites.  
Scaffolds in orthotopic sites will be exposed to bone cells, including osteoblasts, 
osteocytes, and osteoclasts, as well as mechanical loadings.  All these factors will affect 
the rate of bone generation and scaffold degradation.   
We have shown SFF scaffold degradation can be controlled by scaffold initial 
architectures using PLLA.  Further correlation of degradation between the scaffold 
architectures and their materials need to be tested.  Moreover, simulation of mechanical 
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properties of scaffolds, during their in vivo degradation, will be another challenge.  Other 
polymers and their compositions, such as PGA and 85:25PLGA, can be examined to 
determine scaffold architecture effects on each polymer.  It is also important to examine 
larger scaffolds with further complicated architectures, and the local degradation 
differences inside of the scaffolds. 
The scaffolds in this study had homogeneous architectures.  In larger scaffolds, 
composite scaffolds with various architectures and materials can be developed.  For 
example, scaffolds for femur application can have small porous architectures outside and 
large porous architectures at the center for bone marrow space as shown in Fig 7.3.  The 
scaffold with large porous architectures could be made of a fast degrading material, such 
as PLGA and low molecular weight of PLLA, to create space for generating tissues as 
well as allowing easy removal of by-products.  Conversely, the scaffold regions with 
small pore architectures made of slow degradation materials, such as PCL and high 
molecular weight of PLLA, would support long term mechanical loading.  The scaffolds 
can further be incorporated with proteins, DNAs, and genes for local delivery to enhance 
bone formation and reduce inflammation [2-5].  
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Fig 7.3 Example of a composite scaffold with different degradation rate materials and architectures. The 
internal part has large pore size and fast degradation to support tissue generation.  This part also can be 
incorporated with some growth factor, virus etc to enhance tissue formation and reduce inflammatory 
response.   The outer part is made of smaller pore size and slow degradation material to support long term 
mechanical loading at the defect sites. 
 
Lastly, future scaffolds should globally support tissue defects as well as locally 
enhance bone generation.  It has been well documented that mechanical force or stimuli 
effects and regulate stem cells, bone cells and bone formation [6-8].  It also has been 
demonstrated computational model of local and global architectures on bone formation 
[9-12].  And, we have been demonstrated effects of scaffold architectures, such as pore 
size and permeability, on bone formation in vivo as shown in the chapter four and our 
previous papers [13,14].  However, it has not been examined to control of deformation of 
fabricated scaffold pores which cause local strain, pressure and fluid shear stress for the 
sake of bone generation along with global deformation of scaffolds.  Combining the 
information, scaffolds can be computationally designed and fabricated to control 
independent local and global strain to support loads of body and stimulate bone formation 
(Fig 7.4).  Under physiological loadings, the pore designs can be control local strains and 
fluid flow to stimulate cell activities and bone formation. 
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Fig 7.4 Example of control scaffold local and global mechanical properties, before (a) and after (b) 
deformation.  Deformation of local pore should induce local strain as well as fluid shear stress to enhance 
and ostogenesis during loadings.  The architectures of the local pore can determine profiles of local strain 
and fluid shear stress. 
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A. Effect of Computer Designed PLLA Scaffold Permeability on Bone Ingrowth 
In Vivo (TERMIS-NA abstract, 2011) 
 
Introduction: Ideal engineered bone scaffolds should enhance bone ingrowth to support 
defects and degrade in concert with generating bone tissue.  Many studies have reported 
that scaffold architecture parameters, such as permeability, are important factors affecting 
nutrient infiltration and bone ingrowth into porous scaffolds.  The previously reported 
scaffolds, however, were made by conventional techniques, such as salt-leaching, which 
did not rigorously control architectures [1,2].  We have developed designed poly (L-lactic 
acid) (PLLA) porous scaffolds using computer aided design and solid freeform 
fabrication (SFF) techniques. The goal of this study is to determine the effect of designed 
scaffold permeability on bone formation in vivo.   
Methods: Two types of porous PLLA scaffolds (Diameter 6.4mm, Height 3.8mm) with 
different permeability, 0.688 and 3.991 10-7m
4
/N-s, and porosities, 53 and 73 %, were 
computationally designed, and denoted as Low_Perm and, High_Perm, respectively (Fig 
A.1, Top view (a,e), Isometric view (b,f)).  Low_Perm has spherical and necking 
structures of pore connections, while High_Perm has cylindrical and open channels.  The 
designed scaffolds were made of PLLA using an indirect SFF technique. The sterilized 
scaffolds were seeded with fibrin gel containing adenovirus BMP-7 transduced human 
gingival fibroblasts, and were subcutaneously implanted into immuno-compromised mice 
  
165 
 
for 4, 8 and 12 weeks. The scaffolds were scanned using a high resolution Micro-CT 
Scanner before and after implantation.  To determine bone ingrowth, the region of 
interest (ROI) (6.25mm diameter, 2.39mm height) was chosen at the middle of a scaffold.  
Bone volume (BV) and tissue mineral density (TMD) within the ROI were calculated.  
Following Micro-CT analysis, compression tests and histological evaluation with H&E 
were performed. One-way ANOVA or Student t-test was performed to determine 
significance (p<0.05) (N=6-8). 
Results: Fabricated Low_Perm and High_Perm scaffolds had similar architectures and 
porosities, 55.6±4.2 and 73.2±2.1 (%), to the original designs (Fig A.1, pictures (c, g), 
Micro-CT rendering images (d, h)).  The scaffold surface areas were similar to each other, 
362.3±22.2 (Low_Perm) and 341.2±20.4 (High_Perm) (mm
2
).  High_Perm showed 
advanced bone ingrowth all time points, while Low_Perm had advanced bone ingrowth at 
8 and 12 weeks (Fig A.2, indicated by #).  High_Perm had significantly higher bone 
ingrowth than Low_Perm at 8 and 12 weeks, but not at 4 weeks (Fig A.2, indicated by *).  
Compressive moduli showed an initial decrease due to significant scaffold degradation, 
followed by a slight increase because of bone ingrowth (Fig A.3). Similar to micro-CT 
data, H&E images show that small bone ingrowth at 4 weeks, and advanced bone 
ingrowth containing trabecular structures and bone marrow-like tissues at 8 and 12 weeks 
(Fig A.4).   
Discussion and Conclusions:  Both Micro-CT data and histology proved that the 
scaffolds had bone ingrowth after implantation in this study.  Clearly, the highly 
permeable scaffolds supported more bone ingrowth in vivo.  Open channels of 
High_Perm may allow more efficient body fluid infiltration into the scaffolds which 
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helped cell migration and bone tissue ingrowth compared with Low_Perm with necking 
pore connections.   In addition, decrease of the differences of bone ingrowth at 12 weeks 
indicates that higher permeability may be more effective during active bone formation.  
Advanced bone ingrowth supported mechanical properties while both PLLA scaffolds 
degraded and lost their mechanical properties. This study suggests that permeability is an 
important scaffold design factor significantly affecting the rate of bone ingrowth, which 
is favoured by higher permeability.   
Acknowledgement: NIH R01 AR 053379, Micro-CT machine for the ORL at University 
of Michigan 
 
Fig A.1 Designed (a,b,e,f) and fabricated (c,d,g,h) scaffolds 
     
  
Fig A.2 Bone ingrowth after implantation 
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Fig A.3 Compressive moduli at each time point 
 
  
Fig A.4 H&E images of implanted scaffolds 
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B. Engineered Wavy Fibered Porous Polycaprolactone Soft Tissue Scaffolds: 
Design, Fabrication and Mechanical Properties (ORS abstract, 2005) 
 
Introduction:  
     Skeletal soft tissues including meniscal and intervertebral fibrocartilaginous disks, 
cartilage, ligaments, and tendons exhibit a wide range of moduli typically ranging from 
slightly less than 1 MPa to over 100 MPa.  Common scaffolds used to engineer soft 
tissues are typically hydrogels or knit polymers.  These materials cannot withstand the 
extreme range of soft tissue mechanical forces, nor can their design/fabrication be 
controlled to match anisotropic tissue properties.   
     To address the need for soft tissue scaffolds with controlled porosity and mechanical 
properties, we have developed a wavy fiber scaffold design.  We also fabricated these 
complex scaffold architectures from the biodegradable polymer Polycaprolactone (PCL) 
using a Selective Laser Sintering (SLS) technique.  We demonstrate that these scaffolds 
have tightly controlled porosity, yet exhibit a controlled range of moduli and yield strains 
that fall within reported values for many soft tissues. We also show that computational 
simulations reliably predict experimental results, allowing control of scaffold design 
variables including pitch and fiber diameter to match desired anisotropic soft tissue 
properties. 
 
Methods: 
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Curvy Scaffold Design and Fabrication:  
     5 types (n=6) of wavy shape scaffolds were designed using image-based techniques. 
These image-based techniques create wavy fibers based on sine functions (Y = P×Sin(αθ), 
P is pitch, α is const.) for orthogonal interconnecting fibers. Pitch and fiber diameter can 
be rigorously controlled.  Pitch heights for tested designs were 0, 0.1, 0.3, 0.5, and 0.7mm 
(denoted as P0, P1, P3, P5 and P7).  Interconnecting pores were generated as a unit cell 
and replicated to fill the cubic volume.  The resulting image design was converted 
automatically to STL format.  
Scaffold Fabrication: 
     PCL powder (CAPA® 6501, Mn ≈ 50,000, particle size ≤ 100µm) was purchased 
from Solvay Coprolactones (Warrington, UK). Scaffolds were built on a Sinterstation
®
 
2000 SLS machine (3D Systems Inc., Valencia, CA) using a low power CO2 laser (λ = 
10.6µm, CW power < 10W, 450µm spot) to sinter the PCL powder in the desired 3D 
scaffold architecture. 
Micro-Computed Tomography:  
     Porous cube scaffolds were scanned using a MS-130 Micro-CT Scanner (GE Medical 
Systems, Toronto, CAN) at 28 m resolution.  Scaffold volume fraction was calculated 
using Microview software. 
Mechanical Testing:  
     The specimens were uniaxially tested to failure at a rate of 1mm/min after a preload of 
1 lbs. was applied using a MTS Alliance RT30 Electromechanical test frame (MTS 
Systems Corp., MN).  The Modulus was calculated at the first linear portion of the stress 
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strain curve and ultimate strain was taken at peak load before onset of plastic deformation. 
Voxel Homogenization: 
    Designed images were input to a voxel-based homogenization software VOXELCON-
HG (Quint Corp, Tokyo, Japan) to create voxel finite element models.  Complete 
anisotropic effective stiffness constants were computed assuming a base PCL modulus of 
120 MPa from previous tests. 
Results and Conclusions 
     Example designed unit cell, designed scaffold, µCT of actual fabricated scaffold and 
actual fabricated scaffold are shown in Fig B.1.  The unit cell dimension and scaffold 
dimensions were 2.4 × 2.4 × 2.4 (mm) and 12.0 × 12.0 × 24.0 (mm), respectively.  The 
overall mechanical properties and FEM analysis results are shown in Table B.1. The 
average modulus decreased from 17MPa to 4MPa as the pitch height increased in the 
range from 0.1 to 0.7mm, demonstrating a tightly controlled dependence on fiber wave 
pitch for the same volume fraction.  The average moduli of the design P1 through P7 
were within the range of toe and linear region of soft tissues including the supraspinatus 
tendon (17.3 ± 8.9 MPa) [3], human forearm interosseous ligament toe-region modulus 
(roughly estimated at 4MPa from [4]) and annulus fibrosus of the intervertebral disc 
(0.2~2.5MPa for Toe-region and 0.45 ~ 17.4MPa for linear region) [5].  Strains before 
yield ranged from 9 to 32%, also within the failure strains reported for many soft tissues, 
and the highest pitch design exhibited a nonlinear stress-strain curve similar to typical 
soft tissues (Fig B.3).  These ranges were obtained for scaffolds with the same volume 
fraction, demonstrating that scaffolds with designed microstructure can be tailored for 
different soft tissue loading environments, yet have the same porosity for delivering 
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biologic factors.  In the future, we will perform tensile and cyclic loading tests on the 
same designed scaffolds to examine pitch effects on those properties. 
Acknowledgments:  NIH R01 DE13608 (BRP), NIH R21 DE014736 
 
Fig B.1 Example unit cell design (left), scaffold design (2
nd
 from the left), μ-CT rendering (2nd from the 
right) and fabricated scaffold picture (right) 
 
Table B.1 Mechanical properties of scaffolds, FEM (Voxelcon-HG) analysis results and Volume Fraction 
from micro-CT data 
Type of Wave 
Design 
P0 P1 P3 P5 P7 
Hight of Pitch 
(mm) 
0.0 0.1 0.3 0.5 0.7 
Modulus 
(MPa) 
17.23 ± 0.29 17.41 ± 0.18 10.07 ± 0.32 6.30 ± 0.27 4.45 ± 0.12 
Voxelcon HG 
(MPa) 
12.93 11.56 5.91 3.02  1.64 
Ultimate 
Strain (%) 
8.55 ± 0.42 10.79 ± 0.79 15.81 ± 0.60 15.17 ± 4.47 32.43 ± 1.18 
Volume 
Fraction (%) 
29.82 ± 0.38 30.12 ± 0.31 31.91 ± 0.27 32.65 ± 0.30 32.43 ± 0.25 
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Fig B.2 Dependence of compressive moduli on pitch height for both mechanical tests and Voxelcon-HG 
(FEM) analysis. 
 
 
Fig B.3 Stress-Strain Curves from different designs of scaffolds (Line 1: P0, 2: P1, 2: P3, 3: P5, 5: P7)  
 
  
173 
 
References 
[1] Kim K, Dean D, Wallace J, Breithaupt R, Mikos AG, Fisher JP. The influence of 
stereolithographic scaffold architecture and composition on osteogenic signal 
expression with rat bone marrow stromal cells. Biomaterials 2011;32:3750-3763. 
[2] Lee KW, Wang S, Dadsetan M, Yaszemski MJ, Lu L. Enhanced cell ingrowth and 
proliferation through three-dimensional nanocomposite scaffolds with controlled 
pore structures. Biomacromolecules 2010;11:682-689. 
[3] Nightingale EJ, Allen CP, Sonnabend DH, Goldberg J, Walsh WR. Mechanical 
properties of the rotator cuff: response to cyclic loading at varying abduction angles. 
Knee Surg Sports Traumatol Arthrosc 2003;11:389-392. 
[4] Stabile KJ, Pfaeffle J, Weiss JA, Fischer K, Tomaino MM. Bi-directional mechanical 
properties of the human forearm interosseous ligament. J Orthop Res 2004;22:607-
612. 
[5] Elliott DM, Setton LA. Anisotropic and inhomogeneous tensile behavior of the 
human anulus fibrosus: experimental measurement and material model predictions. J 
Biomech Eng 2001;123:256-263. 
 
